Читать книгу Veterinary Surgical Oncology - Группа авторов - Страница 57

1 Aas, M., L. Moe, and H. Gamlenm. 1999. Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm‐ethylenediamino‐tetramethylene‐phosphonate (EDTMP). Clin Cancer Res 5:3148s–3152s.

2 Abadie, J.J., M.A. Amardeilh, and M.E. Delverdier. 1999. Immunohistochemical detection of proliferating cell nuclear antigen and Ki‐67 in mast cell tumors from dogs. J Am Vet Med Assoc 215:1629–34.

3 Abbo, A.H., D.R. Jones, A.R. Masters, et al. 2010. Phase I clinical trial and pharmacokinetics of intravesical mitomycin C in dogs with localized transitional cell carcinoma of the urinary bladder. J Vet Intern Med 24:1124–1130.

4 Adams, W.M., D.E. Bjorling, J.E. Mcanulty, et al. 2005. Outcome of accelerated radiotherapy alone or accelerated radiotherapy followed by exenteration of the nasal cavity in dogs with intranasal neoplasia: 53 cases (1990–2002). J Am Vet Med Assoc 227:936–941.

5 Adams, W.M., M.M. Kleiter, D.E. Thrall, et al. 2009. Prognostic significance of tumor histology and computed tomographic staging for radiation treatment response of canine nasal tumors. Vet Radiol Ultrasound 50:330–335.

6 Adams, W.M., P.E. Miller, D.M. Vail, et al. 1998. An accelerated technique for irradiation of malignant canine nasal and paranasal sinus tumors. Vet Radiol Ultrasound 39:475–81.

7 Adams, W.H., M.A. Walker, G.B. Daniel, et al. 1995. Treatment of differentiated thyroid carcinoma in 7 dogs utilizing 131I. Vet Radiol Ultrasound 36:417.

8 Adams, W.M., S.J. Withrow, R. Walshaw, et al. 1987. Radiotherapy of malignant nasal tumors in 67 dogs. J Am Vet Med Assoc 191:311–315.

9 Affolter, V. and P.F. Moore. 2000. Canine cutaneous histiocytic disease. In Current Veterinary Therapy Xiii: Small Animal Practice. J.D. Bonagura, editor. Philadelphia: Saunders.

10 Alexander, A.N., M.K. Huelsmeyer, A. Mitzey, et al. 2006. Development of an allogeneic whole‐cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma. Cancer Immunol Immunother 55:433–442.

11 Allstadt, S.D., C.O. RodriguezJr., B. Boostrom, et al. 2015. Randomized phase Iii trial of piroxicam in combination with mitoxantrone or carboplatin for first‐line treatment of urogenital tract transitional cell carcinoma in dogs. J Vet Intern Med 29:261–267.

12 AL‐Sarraf, R., G.N. Mauldin, A.K. Patnaik, et al. 1996. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Intern Med 10:376–378.

13 Alvarez, F.J., W. Kisseberth, K. Hosoya, et al. 2014. Postoperative adjuvant combination therapy with doxorubicin and noncytotoxic suramin in dogs with appendicular osteosarcoma. J Am Anim Hosp Assoc 50:12–18.

14 Alwen, S.G., W.T. Culp, A. Szivek, et al. 2015. Portal site metastasis after thoracoscopic resection of a cranial mediastinal mass in a dog. J Am Vet Med Assoc 247:793–800.

15 Amores‐Fuster, I., P. Cripps, and L. Blackwood. 2017. Post‐radiotherapy hypothyroidism in dogs treated for thyroid carcinomas. Vet Comp Oncol 15(1):247–251.

16 Amsellem, P.M., L.E. Selmic, J.M. Wypij, et al. 2014. Appendicular osteosarcoma in small‐breed dogs: 51 cases (1986–2011). J Am Vet Med Assoc 245:203–210.

17 Anderson, C. and K. Pratschke. 2011. Uterine adenocarcinoma with abdominal metastases in an ovariohysterectomised cat. J Feline Med Surg 13:44–47.

18 Argyle, D.J., C.A. London, A.J. Mutsaers, et al. 2013. 14 – Molecular/targeted therapy of cancer. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.

19 Arnell, K., S. Hill, J. Hart, et al. 2013. Persistent regurgitation in four dogs with caudal esophageal neoplasia. J Am Anim Hosp Assoc 49:58–63.

20 Arnold, E.J., M.O. Childress, L.M. Fourez, et al. 2011. Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 25:1385–1390.

21 Aronsohn, M. 1985. Canine thymoma. Vet Clin North Am Small Anim Pract 15:755–767.

22 Aronsohn, M.G. and J.L. Carpenter. 1990. Distal extremity melanocytic nevi and malignant melanomas in dogs. J Am Anim Hosp Assoc 26:605–612.

23 Atwater, S.W., B.E. Powers, R.D. Park, et al. 1994. Thymoma in dogs: 23 cases (1980–1991). J Am Vet Med Assoc 205:1007–1013.

24 Avallone, G., P. Boracchi, D. Stefanello, et al. 2014. Canine perivascular wall tumors: High prognostic impact of site, depth, and completeness of margins. Vet Pathol 51:713–721.

25 Back, A.R., S.E. Schleis, O.A. Smrkovski, et al. 2015. Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs. Vet Comp Oncol 13:398–408.

26 Bacon, N.J., W.S. Dernell, N. Ehrhart, et al. 2007. Evaluation of primary re‐excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999–2004). J Am Vet Med Assoc 230:548–554.

27 Bacon, N.J., N.P. Ehrhart, W.S. Dernell, et al. 2008. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999–2006). J Am Vet Med Assoc 232:1504–1510.

28 Bacon, N.J., R.L. Gilbert, D.E. Bostock, et al. 2003. Total ear canal ablation in the cat: Indications, morbidity and long‐term survival. J Small Anim Pract 44:430–434.

29 Baez, J.L., M.J. Hendrick, F.S. Shofer, et al. 2004. Liposarcomas in dogs: 56 cases (1989–2000). J Am Vet Med Assoc 224:887–891.

30 Baginski, H., G. Davis, and R.P. Bastian. 2014. The prognostic value of lymph node metastasis with grade 2 Mcts in dogs: 55 cases (2001–2010). J Am Anim Hosp Assoc 50:89–95.

31 Banks, T.A., V. Langova, and R.C. Straw. 2003a. Repair of three pathological fractures in a dog with multiple myeloma. Aust Vet Pract 33:98–102.

32 Banks, T.A. and R.C. Straw. 2003. Canine soft tissue sarcomas: Incomplete resection treated with opla‐pt sponges. In. Australian Veterinary Associatoion Annual Conference, Science Week, Australian College of Veterinary Scientists, Surgery Chapter. Gold Coast, Queensland.

33 Banks, T.A., R.C. Straw, M. Thomson, et al. 2004. Soft tissue sarcoma in dogs: A study assessing surgical margin, tumor grade and clinical outcome. Aust Vet Pract 34:158–163.

34 Banks, T.A., R.C. Straw, S.J. Withrow, et al. 2003b. Prospective study of canine soft tissue sarcoma treated by wide surgical excision: Quantitative evaluation of surgical margins. In The 23rd Annual Conference of the Veterinary Cancer Society, Madison, WI, p. 21.

35 Bannink, E.O., M.L. Sauerbrey, M.N. Mullins, et al. 2008. Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999–2006). J Am Vet Med Assoc 233:446–451.

36 Barber, L.G., K.U. Sorenmo, K.L. Cronin, et al. 2000. Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma. J Am Anim Hosp Assoc 36:416–421.

37 Barnard, R.A., L.A. Wittenburg, R.K. Amaravadi, et al. 2014. Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Autophagy 10:1415–1425.

38 Barnard, S.M., R.M. Zuber, and A.S. Moore. 2007. Samarium Sm 153 lexidronam for the palliative treatment of dogs with primary bone tumors: 35 cases (1999–2005). J Am Vet Med Assoc 230:1877–1881.

39 Barnes, D.C. and J.L. Demetriou. 2017. Surgical management of primary, metastatic and recurrent anal sac adenocarcinoma in the dog: 52 cases. J Small Anim Pract 58:263–268.

40 Basinger, R.R., C.A. Rawlings, J.A. Barsanti, et al. 1989. Urodynamic alterations associated with clinical prostatic diseases and prostatic surgery in 23 dogs. J Am Anim Hosp Assoc 25:385–392.

41 Bateman, K.E., P.A. Catton, P.W. Pennock, et al. 1994. 0‐7‐21 radiation therapy for the treatment of canine oral melanoma. J Vet Intern Med 8:267–272.

42 Batschinski, K., N.G. Dervisis, and B.E. Kitchell. 2014. Evaluation of ifosfamide salvage therapy for metastatic canine osteosarcoma. Vet Comp Oncol 12:249–257.

43 Bearss, J.J., F.Y. Schulman, and D. Carter. 2012. Histologic, immunohistochemical, and clinical features of 27 mammary tumors in 18 male dogs. Vet Pathol 49:602–607.

44 Beauvais, W., J.M. Cardwell, and D.C. Brodbelt. 2012. The effect of neutering on the risk of mammary tumours in dogs–a systematic review. J Small Anim Pract 53:314–322.

45 Beaver, L.M., G. Strottner, and M.K. Klein. 2010. Response rate after administration of a single dose of doxorubicin in dogs with B‐cell or T‐cell lymphoma: 41 cases (2006–2008). J Am Vet Med Assoc 237:1052–1055.

46 Bennett, P.F., D.B. Denicola, P. Bonney, et al. 2002. Canine anal sac adenocarcinomas: Clinical presentation and response to therapy. J Vet Intern Med 16:100–104.

47 Berg, J., M.C. Gebhardt, and W.M. Rand. 1997. Effect of timing of postoperative chemotherapy on survival of dogs with osteosarcoma. Cancer 79:1343–1350.

48 Berg, J., M.J. Weinstein, S.H. Schelling, et al. 1992. Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb‐sparing surgery: 22 cases (1987–1990). J Am Vet Med Assoc 200:2005–2008.

49 Berg, J., M.J. Weinstein, D.S. Springfield, et al. 1995. Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma. J Am Vet Med Assoc 206:1555–1560.

50 Bergman, P.J., M.A. Camps‐Palau, J.A. Mcknight, et al. 2003a. Development of a xenogeneic DNA vaccine program for canine malignant melanoma with prolongation of survival in dogs with locoregionally controlled stage II–II disease. In Proceedings of the 23rd Annual Conference of the Veterinary Cancer Society, Madison, WI, 23: 40.

51 Bergman, P.J., M.A. Camps‐Palau, J.A. Mcknight, et al. 2004. Phase I & IB trials of murine tyrosinase ± human GM‐Csf Dna vaccination in dogs with advanced malignant melanoma. Vet Cancer Soc Proc 24:55.

52 Bergman, P.J., M.A. Camps‐Palau, J.A. Mcknight, et al. 2006. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 24:4582–4585.

53 Bergman, P.J., M.S. Kent, and J.P. Farese. 2013. 19 – Melanoma. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.

54 Bergman, P.J., E.G. Macewen, I.D. Kurzman, et al. 1996. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991–1993). J Vet Intern Med 10:76–81.

55 Bergman, P.J., J. Mcknight, A. Novosad, et al. 2003b. Long‐term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: A phase I trial. Clin Cancer Res 9:1284–1290.

56 Bergman, P.J., S.J. Withrow, R.C. Straw, et al. 1994. Infiltrative lipoma in dogs: 16 cases (1981–1992). J Am Vet Med Assoc 205:322–324.

57 Berlato, D., D. Schrempp, N. Van Den Steen, et al. 2012. Radiotherapy in the management of localized mucocutaneous oral lymphoma in dogs: 14 cases. Vet Comp Oncol 10:16–23.

58 Bertelli, G., A. Gozza, G.B. Forno, et al. 1995. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: A prospective clinical study. J Clin Oncol 13:2851–2855.

59 Betz, D., D. Schoenrock, R. Mischke, et al. 2012. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre‐ and postoperatively available information. Tierarztl Prax Ausg K Kleintiere Heimtiere 40:235–242.

60 Bianco, S.R., J. Sun, S.P. Fosmire, et al. 2003. Enhancing antimelanoma immune responses through apoptosis. Cancer Gene Ther 10:726–736.

61 Biller, B. 2014. Metronomic chemotherapy in veterinary patients with cancer: Rethinking the targets and strategies of chemotherapy. Vet Clin North Am Small Anim Pract 44:817–829.

62 Birchard, S.J. 2006. Thyroidectomy in the cat. Clin Tech Small Anim Pract 21:29–33.

63 Blackburn, A.L., A.C. Berent, C.W. Weisse, et al. 2013. Evaluation of outcome following urethral stent placement for the treatment of obstructive carcinoma of the urethra in dogs: 42 cases (2004–2008). J Am Vet Med Assoc 242:59–68.

64 Blackwood, L. and J.M. Dobson. 1996. Radiotherapy of oral malignant melanomas in dogs. J Am Vet Med Assoc 209:98–102.

65 Bland, K.I., W.E. Palin, J.A. Von Fraunhofer, et al. 1984. Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Ann Surg 199:782–790.

66 Bleakley, S., C.G. Duncan, and E. Monnet. 2015. Thoracoscopic lung lobectomy for primary lung tumors in 13 dogs. Vet Surg 44:1029–1035.

67 Bolon, B., M.B. Calderwood Mays, and B.J. Hall. 1990. Characteristics of canine melanomas and comparison of histology and DNA ploidy to their biologic behavior. Vet Pathol 27:96–102.

68 Bommarito, D.A., M.S. Kent, K.A. Selting, et al. 2011. Reirradiation of recurrent canine nasal tumors. Vet Radiol Ultrasound 52:207–212.

69 Bommer, N.X., A.M. Hayes, T.J. Scase, et al. 2012. Clinical features, survival times and Cox‐1 and Cox‐2 expression in cats with transitional cell carcinoma of the urinary bladder treated with meloxicam. J Feline Med Surg 14:527–533.

70 Boretti, F.S., N.S. Sieber‐Ruckstuhl, S. Schafer, et al. 2013. Duration of t4 suppression in hyperthyroid cats treated once and twice daily with transdermal methimazole. J Vet Intern Med 27:377–381.

71 Boretti, F.S., N.S. Sieber‐Ruckstuhl, S. Schafer, et al. 2014. Transdermal application of methimazole in hyperthyroid cats: A long‐term follow‐up study. J Feline Med Surg 16:453–459.

72 Boria, P.A., N.W. Glickman, B.R. Schmidt, et al. 2005. Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder. Vet Comp Oncol 3:73–80.

73 Boria, P.A., D.J. Murry, P.F. Bennett, et al. 2004. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs. J Am Vet Med Assoc 224:388–394.

74 Borrego, J.F., J.C. Cartagena, and J. Engel. 2009. Treatment of feline mammary tumours using chemotherapy, surgery and a Cox‐2 inhibitor drug (meloxicam): A retrospective study of 23 cases (2002–2007) . Vet Comp Oncol 7:213–221.

75 Bostock, D.E. and M.T. Dye. 1980. Prognosis after surgical excision of canine fibrous connective tissue sarcomas. Vet Pathol 17:581–588.

76 Boston, S.E., M. Barry, M.L. and O’Sullivan. 2011. Transtumoral plating as a novel method for palliative limb spare and thromboembolism in a dog with a distal radial primary bone tumor. Can Vet J 52:650–655.

77 Boston, S.E., F. Duerr, N. Bacon, et al. 2007. Intraoperative radiation for limb sparing of the distal aspect of the radius without transcarpal plating in five dogs. Vet Surg 36:314–323.

78 Boston, S.E., X. Lu, W.T. Culp, et al. 2014. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001–2012). J Am Vet Med Assoc 245:401–407.

79 Boston, S. and A. Singh. 2014. Total cystectomy for treatment of transitional cell carcinoma of the urethra and bladder trigone in a dog. Vet Surg 43:294–300.

80 Boston, S.E. and O.T. Skinner. 2018. Limb shortening as a strategy for limb sparing treatment of appendicular osteosarcoma of the distal radius in a dog. Vet Surg 47:136–145.

81 Boston, S.E., A. Vinayak, X. Lu, et al. 2017. Outcome and complications in dogs with appendicular primary bone tumors treated with stereotactic radiotherapy and concurrent surgical stabilization. Vet Surg 46:829–837.

82 Bowles, K., D. Desandre‐Robinson, L. Kubicek, et al. 2016. Outcome of definitive fractionated radiation followed by exenteration of the nasal cavity in dogs with sinonasal neoplasia: 16 cases. Vet Comp Oncol. 14(4):350–360.

83 Boyce, K.L. and B.E. Kitchell. 2000. Treatment of canine lymphoma with Copla/Lvp. J Am Anim Hosp Assoc 36:395–403.

84 Bracha, S., R. Walshaw, T. Danton, et al. 2014. Evaluation of toxicities from combined metronomic and maximal‐tolerated dose chemotherapy in dogs with osteosarcoma. J Small Anim Pract 55:369–374.

85 Bradley, R.L., E.G. Macewen, and A.S. Loar. 1984. Mandibular resection for removal of oral tumors in 30 dogs and 6 cats. J Am Vet Med Assoc 184:460–463.

86 Bray, J.P., G.A. Polton, K.D. Mcsporran, et al. 2014a. Canine soft tissue sarcoma managed in first opinion practice: Outcome in 350 cases. Vet Surg 43:774–782.

87 Bray, J.P., D.R. Worley, R.A. Henderson, et al. 2014b. Hemipelvectomy: Outcome in 84 dogs and 16 cats. A veterinary society of surgical oncology retrospective study. Vet Surg 43:27–37.

88 Brearley, M.J., A.M. Hayes, and S. Murphy. 1999. Hypofractionated radiation therapy for invasive thyroid carcinoma in dogs: A retrospective analysis of survival. J Small Anim Pract 40:206–210.

89 Bregazzi, V.S., S.M. Larue, E. McNiel, et al. 2001. Treatment with a combination of doxorubicin, surgery, and radiation versus surgery and radiation alone for cats with vaccine‐associated sarcomas: 25 cases (1995–2000). J Am Vet Med Assoc 218:547–550.

90 Brehm, D.M., C.H. Vite, H.S. Steinberg, et al. 1995. A retrospective evaluation of 51 cases of peripheral nerve sheath tumors in the dog. J Am Anim Hosp Assoc 31:349–359.

91 Brewer, W.G., Jr. and J.M. Turrel. 1982. Radiotherapy and hyperthermia in the treatment of fibrosarcomas in the dog. J Am Vet Med Assoc 181:146–150.

92 Brockley, L.K., M.A. Cooper, and P.F. Bennett. 2013. Malignant melanoma in 63 dogs (2001‐2011): The effect of carboplatin chemotherapy on survival. N Z Vet J 61:25–31.

93 Brodey, R.S., M.A. Goldschmidt, and J.R. Roszel. 1983. Canine mammary gland neoplasms. J Am Anim Hosp Assoc 19:61–90.

94 Brodsky, E.M., G.N. Maudlin, J.L. Lachowicz, et al. 2009. Asparaginase and Mopp treatment of dogs with lymphoma. J Vet Intern Med 23:578–584.

95 Brooks, M.B., R.E. Matus, C.E. Leifer, et al. 1987. Use of splenectomy in the management of lymphoma in dogs: 16 cases (1976–1985). J Am Vet Med Assoc 191:1008–1010.

96 Broome, M.R., M.E. Peterson, and J.R. Walker. 2014. Clinical features and treatment outcomes of 41 dogs with sublingual ectopic thyroid neoplasia. J Vet Intern Med 28:1560–1568.

97 Brown, N.O., A.K. Patnaik, and E.G. MacEwen. 1985. Canine hemangiosarcoma: Retrospective analysis of 104 cases. J Am Vet Med Assoc 186:56–58.

98 Brunnert, S.R., L.A. Dee, A.J. Herron, et al. 1992. Gastric extramedullary plasmacytoma in a dog. J Am Vet Med Assoc 200:1501–1502.

99 Buchholz, J., R. Hagen, C. Leo, et al. 2009. 3D conformal radiation therapy for palliative treatment of canine nasal tumors. Vet Radiol Ultrasound 50:679–683.

100 Budreckis, D.M., B.A. Byrne, R.E. Pollard, et al. 2015. Bacterial urinary tract infections associated with transitional cell carcinoma in dogs. J Vet Intern Med 29:828–833.

101 Buijtels, J.J., I.A. Kurvers, S. Galac, et al. 2006. [Transdermal carbimazole for the treatment of feline hyperthyroidism]. Tijdschr Diergeneeskd 131:478–482.

102 Bulakowski, E.J., J.C. Philibert, S. Siegel, et al. 2008. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001–2006). J Am Vet Med Assoc 233:122–128.

103 Buracco, P., E. Morello, M. Martano, et al. 2002. Pasteurized tumoral autograft as a novel procedure for limb sparing in the dog: A clinical report. Vet Surg 31:525–532.

104 Burton, J.H., E. Garrett‐Mayer, and D.H. Thamm. 2013. Evaluation of a 15‐week CHOP protocol for the treatment of canine multicentric lymphoma. Vet Comp Oncol 11:306–315.

105 Burton, J.H., L. Mitchell, D.H. Thamm, et al. 2011. Low‐dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma. J Vet Intern Med 25:920–926.

106 Burton, J.H., R.O. Venable, D.M. Vail, et al. 2015. Pulse‐administered toceranib phosphate plus lomustine for treatment of unresectable mast cell tumors in dogs. J Vet Intern Med 29:1098–1104.

107 Cahalane, A.K., S. Payne, L.G. Barber, et al. 2004. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994–2002). J Am Vet Med Assoc 225:401–408.

108 Campos, M., R. Ducatelle, G. Rutteman, et al. 2014. Clinical, pathologic, and immunohistochemical prognostic factors in dogs with thyroid carcinoma. J Vet Intern Med 28:1805–1813.

109 Cancedda, S., L. Marconato, V. Meier, et al. 2016a. Hypofractionated radiotherapy for macroscopic canine soft tissue sarcoma: A retrospective study of 50 cases treated with a 5 × 6 gy protocol with or without metronomic chemotherapy. Vet Radiol Ultrasound 57(1):75–83.

110 Cancedda, S., C. Rohrer Bley, L. Aresu, et al. 2016b. Efficacy and side effects of radiation therapy in comparison with radiation therapy and temozolomide in the treatment of measurable canine malignant melanoma. Vet Comp Oncol 14(4):e146–e157.

111 Cancedda, S., S. Sabattini, G. Bettini, et al. 2015. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma. Vet Radiol Ultrasound 56:335–343.

112 Cannon, C., A. Borgatti, M. Henson, et al. 2015. Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma. J Small Anim Pract 56:425–429.

113 Carberry, C.A., J.A. Glanders, H.J. Harvey, et al. 1988. Salivary gland tumors in dogs and cats: A literature and case review. J Am Anim Hosp Assoc 24:561–567.

114 Carlsten, K.S., C.A. London, S. Haney, et al. 2012. Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors. J Vet Intern Med 26:135–141.

115 Carter, R.F., C.K. Harris, S.J. Withrow, et al. 1987. Chemotherapy of canine lymphoma with histopathological correlation: Doxorubicin alone compared to COP as first treatment regimen. J Am Anim Hosp Assoc 23:221–225.

116 Carver, J.R., A. Kapatkin, and A.K. Patnaik. 1995. A comparison of medullary thyroid carcinoma and thyroid adenocarcinoma in dogs: A retrospective study of 38 cases. Vet Surg 24:315–319.

117 Case, J.B., C.M. Macphail, and S.J. Withrow. 2012. Anatomic distribution and clinical findings of intermuscular lipomas in 17 dogs (2005–2010). J Am Anim Hosp Assoc 48:245–249.

118 Cavalcanti, J.V., M.P. Moura, and F.O. Monteiro. 2014. Thymoma associated with exfoliative dermatitis in a cat. J Feline Med Surg 16:1020–1023.

119 Cemezar, M., J.A. Avgustin, D. Pavlin, et al. 2017. Efficacy and safety of electrochemotherapy combined with peritumoral IL‐12 gene electrotransfer of canine mast cell tumors. Vet Comp Oncol 15:641–654.

120 Cerf, D.J. and E.C. Lindquist. 2012. Palliative ultrasound‐guided endoscopic diode laser ablation of transitional cell carcinomas of the lower urinary tract in dogs. J Am Vet Med Assoc 240:51–60.

121 Chaffin, K. and D.E. Thrall. 2002. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis. Vet Radiol Ultrasound 43:392–395.

122 Chakraborty, S., L. Balogh, T. Das, et al. 2016. Evaluation of 177Lu‐EDTMP in dogs with spontaneous tumor involving bone: Pharmacokinetics, dosimetry and therapeutic efficacy. Curr Radiopharm 9:64–70.

123 Charney, S.C., P.J. Bergman, J.A. Mcknight, et al. 2005. Evaluation of intracavitary mitoxantrone and carboplatin for treatment of carcinomatosis, sarcomatosis and mesothelioma, with or without malignant effusions: A retrospective analysis of 12 cases (1997–2002). Vet Comp Oncol 3:171–181.

124 Chase, D., J. Bray, A. Ide, et al. 2009. Outcome following removal of canine spindle cell tumours in first opinion practice: 104 cases. J Small Anim Pract 50:568–574.

125 Cheli, R., F. Addis, C.M. Mortellaro, et al. 1987. Photodynamic therapy of spontaneous animal tumors using the active component of hematoporphyrin derivative (DHE) as photosensitizing drug: Clinical results. Cancer Lett 38:101–105.

126 Chen, C.L., M.H. Sun, D.C. Tan, et al. 2004. Comparison of pelvic transarterial chemoembolization with lipiodol ultra‐fluid carboplatin and transarterial carboplatin through experiment in dogs. Ai Zheng 23:1405–1408.

127 Chun, R. 2009. Lymphoma: Which chemotherapy protocol and why? Top Companion Anim Med 24:157–162.

128 Chun, R., L.D. Garrett, C. Henry, et al. 2005. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma. J Am Anim Hosp Assoc 41:382–387.

129 Chun, R., L.D. Garrett, and D.M. Vail. 2000. Evaluation of a high‐dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 14:120–124.

130 Church, E.M., C.J. Mehlhaff, and A.K. Patnaik. 1987. Colorectal adenocarcinoma in dogs: 78 cases (1973–1984). J Am Vet Med Assoc 191:727–730.

131 Ciekot, P.A., B.E. Powers, S.J. Withrow, et al. 1994. Histologically low‐grade, yet biologically high‐grade, fibrosarcomas of the mandible and maxilla in dogs: 25 cases (1982–1991). J Am Vet Med Assoc 204:610–615.

132 Clemente, M., P.J. de Andres, L. Pena, et al. 2009. Survival time of dogs with inflammatory mammary cancer treated with palliative therapy alone or palliative therapy plus chemotherapy. Vet Rec 165:78–81.

133 Clifford, C.A., K.A. Skorupski, and P.F. Moore. 2012. Histiocytic diseases. In Withrow and MacEwen’s Small Animal Clinical Oncology, 5th edition. S.J. Withrow, D.M. Vail, and R. Page, editors. Philadelphia: W. B. Saunders.

134 Closa, J.M., A. Font, and J. Mascort. 1999. Pericardial mesothelioma in a dog: Long‐term survival after pericardiectomy in combination with chemotherapy. J Small Anim Pract 40:383–386.

135 Cohen, M., J.C. Wright, W.R. Brawner, et al. 2001. Use of surgery and electron beam irradiation, with or without chemotherapy, for treatment of vaccine‐associated sarcomas in cats: 78 cases (1996–2000). J Am Vet Med Assoc 219:1582–1589.

136 Coleman, K.A., A.C. Berent, and C.W. Weisse. 2014. Endoscopic mucosal resection and snare polypectomy for treatment of a colorectal polypoid adenoma in a dog. J Am Vet Med Assoc 244:1435–1440.

137 Collette, S.A., S.D. Allstadt, E.M. Chon, et al. 2016. Treatment of feline intermediate‐ to high‐grade lymphoma with a modified university of Wisconsin‐Madison protocol: 119 cases (2004–2012). Vet Comp Oncol. 14(1):136–146.

138 Constantino‐Casas, F., D. Mayhew, T.M. Hoather, et al. 2011. The clinical presentation and histopathologic‐immunohistochemical classification of histiocytic sarcomas in the Flat Coated Retriever. Vet Pathol 48:764–771.

139 Coomer, A., J. Farese, R. Milner, et al. 2009. Radiation therapy for canine appendicular osteosarcoma. Vet Comp Oncol 7:15–27.

140 Cooper, M., X. Tsai, and P. Bennett. 2009. Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases. Vet Comp Oncol 7:196–206.

141 Cotter, S.M. and M.A. Goldstein. 1983. Treatment of lymphoma and leukaemia with cyclophosphamide, vincristine and prednisolone: I Treatment of the dog. J Am Anim Hosp Assoc 19:159–165.

142 Covey, J.L., J.P. Farese, N.J. Bacon, et al. 2014. Stereotactic radiosurgery and fracture fixation in 6 dogs with appendicular osteosarcoma. Vet Surg 43:174–181.

143 Craig, L.E., M.E. Julian, and J.D. Ferracone. 2002. The diagnosis and prognosis of synovial tumors in dogs: 35 cases. Vet Pathol 39:66–73.

144 Cristofanilli, M., A.U. Buzdar, N. Sneige, et al. 2001. Paclitaxel in the multimodality treatment for inflammatory breast carcinoma. Cancer 92:1775–1782.

145 Cronin, K., R.L. Page, G. Spodnick, et al. 1998. Radiation therapy and surgery for fibrosarcoma in 33 cats. Vet Radiol Ultrasound 39:51–56.

146 Crow, S.E., G.H. Theilen, E. Benjaminini, et al. 1977. Chemoimmunotherapy for canine lymphosarcoma. Cancer 40:2102–2108.

147 Culbertson, M.R., Jr. 1982. Hemangiosarcoma of the canine skin and tongue. Vet Pathol 19:556–558.

148 Culp, W.T., C.M. Macphail, J.A. Perry, et al. 2011. Use of a nitinol stent to palliate a colorectal neoplastic obstruction in a dog. J Am Vet Med Assoc 239:222–227.

149 Culp, W.T., C. Weisse, A.C. Berent, et al. 2015. Early tumor response to intraarterial or intravenous administration of carboplatin to treat naturally occurring lower urinary tract carcinoma in dogs. J Vet Intern Med 29:900–907.

150 Cunha, S.C., K.B. Corgozinho, H.J. Souza, et al. 2015. Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy. J Feline Med Surg 17:1000–1004.

151 Curran, K.M., C.H. Halsey, and D.R. Worley. 2016. Lymphangiosarcoma in 12 dogs: A case series (1998–2013). Vet Comp Oncol 14(2):181–190.

152 Curran, K. and D.H. Thamm. 2016. Retrospective analysis for treatment of naive canine multicentric lymphoma with a 15‐week, maintenance‐free CHOP protocol. Vet Comp Oncol. 14 Suppl 1:147–155.

153 Daminet, S., H.S. Kooistra, F. Fracassi, et al. 2014. Best practice for the pharmacological management of hyperthyroid cats with antithyroid drugs. J Small Anim Pract 55:4–13.

154 Dank, G., K.M. Rassnick, Y. Sokolovsky, et al. 2014. Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision. Vet Comp Oncol 12:78–84.

155 Danova, N.A., J.C. Robles‐Emanuelli, and D.E. Bjorling. 2006. Surgical excision of primary canine rectal tumors by an anal approach in twenty‐three dogs. Vet Surg 35:337–340.

156 Daters, A.T., G.E. Mauldin, G.N. Mauldin, et al. 2010. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP‐MA) for the treatment of canine lymphoma. Vet Comp Oncol 8:11–22.

157 Davidson, E.B., C.R. Gregory, and P.H. Kass. 1997. Surgical excision of soft tissue fibrosarcomas in cats. Vet Surg 26:265–269.

158 Davies, D.R., K.M. Wyatt, J.E. Jardine, et al. 2004. Vinblastine and prednisolone as adjunctive therapy for canine cutaneous mast cell tumors. J Am Anim Hosp Assoc 40:124–130.

159 De Lorenzi, D., D. Bertoncello, and A. Dentini. 2015. Intraoral diode laser epiglottectomy for treatment of epiglottis chondrosarcoma in a dog. J Small Anim Pract 56:675–678.

160 De Souza, C.H.M., E. Toledo‐Piza, R. Amorin, et al. 2009. Inflammatory mammary carcinoma in 12 dogs: Clinical features, cyclooxygenase‐2 expression, and response to piroxicam treatment. Can Vet J 50:506–510.

161 De Vos, J., S. Ramos Vega, E. Noorman, et al. 2012. Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib. Vet Comp Oncol 10:206–213.

162 Demetriou, J.L., M.J. Brearley, F. Constantino‐Casas, et al. 2012. Intentional marginal excision of canine limb soft tissue sarcomas followed by radiotherapy. J Small Anim Pract 53:174–181.

163 Dernell, W.S., R.C. Straw, M.F. Cooper, et al. 1998a. Multilobular osteochondrosarcoma in 39 dogs: 1979–1993. J Am Anim Hosp Assoc 34:11–18.

164 Dernell, W.S., S.J. Withrow, C.A. Kuntz, et al. 1998b. Principles of treatment for soft tissue sarcoma. Clin Tech Small Anim Pract 13:59–64.

165 Dervisis, N.G., P.A. Dominguez, R.G. Newman, et al. 2011. Treatment with DAV for advanced‐stage hemangiosarcoma in dogs. J Am Anim Hosp Assoc 47:170–178.

166 Dervisis, N.G., P.A. Dominguez, L. Sarbu, et al. 2007. Efficacy of temozolomide or dacarbazine in combination with an anthracycline for rescue chemotherapy in dogs with lymphoma. J Am Vet Med Assoc 231:563–569.

167 Dervisis, N.G. and B.E. Kitchell. 2010. Dacarbazine as single‐agent therapy for relapsed lymphoma in dogs. J Vet Intern Med 24:4; author reply 5.

168 Dhawan, D., J.A. Ramos‐Vara, J.F. Naughton, et al. 2013. Targeting folate receptors to treat invasive urinary bladder cancer. Cancer Res 73:875–884.

169 Dobson, J., S. Cohen, and S. Gould. 2004. Treatment of canine mast cell tumours with prednisolone and radiotherapy. Vet Comp Oncol 2:132–141.

170 Donnelly, L., C. Mullin, J. Balko, et al. 2015. Evaluation of histological grade and histologically tumour‐free margins as predictors of local recurrence in completely excised canine mast cell tumours. Vet Comp Oncol 13:70–76.

171 Dougherty, T.J., R.E. Thoma, D.G. Boyle, et al. 1981. Interstitial photoradiation therapy for primary solid tumors in pet cats and dogs. Cancer Res 41:401–404.

172 Dow, S.W., R.E. Elmslie, A.P. Willson, et al. 1998. in vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma. J Clin Invest 101:2406–2414.

173 Drake, D.B. and S.N. Oishi. 1995. Wound healing considerations in chemotherapy and radiation therapy. Clin Plast Surg 22:31–37.

174 Drazner, F.H. 1982. Multiple myeloma in the cat. Comp Contin Educ 4:206–216.

175 Dunning, D., E. Monnet, E.C. Orton, et al. 1998. Analysis of prognostic indicators for dogs with pericardial effusion: 46 cases (1985–1996). J Am Vet Med Assoc 212:1276–1280.

176 Eckstein, C., F. Guscetti, M. Roos, et al. 2009. A retrospective analysis of radiation therapy for the treatment of feline vaccine‐associated sarcoma. Vet Comp Oncol 7:54–68.

177 Ehrhart, N. 2005a. Longitudinal bone transport for treatment of primary bone tumors in dogs: Technique description and outcome in 9 dogs. Vet Surg 34:24–34.

178 Ehrhart, N. 2005b. Soft‐tissue sarcomas in dogs: A review. J Am Anim Hosp Assoc 41:241–246.

179 Ehrhart, N.P., J.A. Eurell, P.D. Constable, et al. 2005. The effect of host tissue irradiation on large‐segment allograft incorporation. Clin Orthop Relat Res 435:43–‐51.

180 Ehrhart, N.P., S.D. Ryan, and T.M. Fan. 2013. 24 – Tumors of the skeletal system. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.

181 Eisenschenk, A., C. Witzel, M. Lautenbach, et al. 2006. Impact of radiation therapy on healing and stability of vascularized bone grafts in a dog model. Microsurgery 26:412–416.

182 Elliott, J.W., P. Cripps, A.M. Marrington, et al. 2013. Epirubicin as part of a multi‐agent chemotherapy protocol for canine lymphoma. Vet Comp Oncol 11:185–198.

183 Elmslie, R. 1997. Combination chemotherapy with and without surgery for dogs with high grade mast cell tumors with regional lymph node metastases. Vet Cancer Soc Newsl 20:6–7.

184 Elmslie, R.E., S.W. Dow, and T.A. Potter. 1994. Genetic immunotherapy of canine oral melanoma. Vet Cancer Soc Proc 14:111.

185 Elmslie, R.E., P. Glawe, and S.W. Dow. 2008. Metronomic therapy with cyclophosphamide and piroxicam effectively delays tumor recurrence in dogs with incompletely resected soft tissue sarcomas. J Vet Intern Med 22:1373–1379.

186 Elmslie, R.E., T.A. Potter, and S.W. Dow. 1995. Direct DNA injection for the treatment of malignant melanoma. Vet Cancer Soc Proc 15:52.

187 Elston, L.B., F.A. Sueiro, J.N. Cavalcanti, et al. 2009. The importance of the mitotic index as a prognostic factor for survival of canine cutaneous mast cell tumors: A validation study. Vet Pathol 46:362–364, author reply 364–365.

188 Emms, S.G. 2005. Anal sac tumours of the dog and their response to cytoreductive surgery and chemotherapy. Aust Vet J 83:340–343.

189 Epple, L.M., L.T. Bemis, R.P. Cavanaugh, et al. 2013. Prolonged remission of advanced bronchoalveolar adenocarcinoma in a dog treated with autologous, tumour‐derived chaperone‐rich cell lysate (Crcl) vaccine. Int J Hyperthermia 29:390–398.

190 Esplin, D.G. 2008. Survival of dogs following surgical excision of histologically well‐differentiated melanocytic neoplasms of the mucous membranes of the lips and oral cavity. Vet Pathol 45:889–896.

191 Evans, S.M. 1987. Canine haemangiopericytoma: A retrospective analysis of response to surgery and orthovoltage radiation. Vet Radiol 28:13.

192 Evans, S.M., M. Goldschmidt, L.J. Mckee, et al. 1989. Prognostic factors and survival after radiotherapy for intranasal neoplasms in dogs: 70 cases (1974–1985). J Am Vet Med Assoc 194:1460–1463.

193 Evans, S.M. and D.E. Thrall. 1983. Postoperative orthovoltage radiation therapy of parotid salivary gland adenocarcinoma in three dogs. J Am Vet Med Assoc 182:993–994.

194 Fahey, C.E., R.J. Milner, K. Barabas, et al. 2011. Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003–2009). J Am Vet Med Assoc 239:209–215.

195 Fan, T.M. 2007. The role of bisphosphonates in the management of patients that have cancer. Vet Clin North Am Small Anim Pract 37:1091–1110; vi.

196 Fan, T.M. 2009. Intravenous aminobisphosphonates for managing complications of malignant osteolysis in companion animals. Top Companion Anim Med 24:151–156.

197 Fan, T.M., S.C. Charney, L.P. De Lorimier, et al. 2009. Double‐blind placebo‐controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain. J Vet Intern Med 23:152–160.

198 Fan, T.M., L.P. De Lorimier, S.C. Charney, et al. 2005. Evaluation of intravenous pamidronate administration in 33 cancer‐bearing dogs with primary or secondary bone involvement. J Vet Intern Med 19:74–80.

199 Fan, T.M., L.P. De Lorimier, L.D. Garrett, et al. 2008. The bone biologic effects of zoledronate in healthy dogs and dogs with malignant osteolysis. J Vet Intern Med 22:380–387.

200 Fan, T.M., L.P. De Lorimier, K. O’dell‐Anderson, et al. 2007. Single‐agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain. J Vet Intern Med 21:431–439.

201 Fan, T.M., B.E. Kitchell, R.S. Dhaliwal, et al. 2002. Haematological toxicity and therapeutic efficacy of lomustine in 20 tumor‐bearing cats: Critical assessment of a practical dosing regimen. J Am Anim Hosp Assoc 38:357–363.

202 Farese, J.P., J. Kirpensteijn, M. Kik, et al. 2009. Biologic behavior and clinical outcome of 25 dogs with canine appendicular chondrosarcoma treated by amputation: A Veterinary Society of Surgical Oncology retrospective study. Vet Surg 38:914–919.

203 Farese, J.P., R. Milner, M.S. Thompson, et al. 2004. Stereotactic radiosurgery for treatment of osteosarcomas involving the distal portions of the limbs in dogs. J Am Vet Med Assoc 225:1567–1572, 1548.

204 Farrelly, J., D.L. Denman, A.E. Hohenhaus, et al. 2004. Hypofractionated radiation therapy of oral melanoma in five cats. Vet Radiol Ultrasound 45:91–93.

205 Feldman, E.C. and R.W. Nelson. 2004. Beta‐cell neoplasia: Insulinomas. In Canine and Feline Endocrinology and Reproduction, 3rd edition. Feldman, E.C. and R.W. Nelson, editors. St. Louis: Saunders.

206 Fineman, L.S., T.A. Hamilton, A. De Gortari, et al. 1998. Cisplatin chemotherapy for treatment of thyroid carcinoma in dogs: 13 cases. J Am Anim Hosp Assoc 34:109–112.

207 Finocchiaro, L.M. and G.C. Glikin. 2012. Cytokine‐enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma: 9 years of follow‐up. Cancer Gene Ther 19:852–861.

208 Flanders, J.A. 1999. Surgical options for the treatment of hyperthyroidism in the cat. J Feline Med Surg 1:127–134.

209 Flanders, J.A., H.J. Harvey, and H.N. Erb. 1987. Feline thyroidectomy. A comparison of postoperative hypocalcemia associated with three different surgical techniques. Vet Surg 16:362–366.

210 Flory, A.B., K.M. Rassnick, R. Al‐Sarraf, et al. 2008. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs. J Vet Intern Med 22:164–171.

211 Flory, A.B., K.M. Rassnick, H.N. Erb, et al. 2011. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000–2007). J Am Vet Med Assoc 238:501–506.

212 Fonda, D., M. Gualtieri, and E. Scanziani. 1989. Gastric carcinoma in the dog: A clinicopathological study of 11 cases. J Small Anim Pract 30:353–360.

213 Forrest, L.J., R. Chun, W.M. Adams, et al. 2000. Postoperative radiotherapy for canine soft tissue sarcoma. J Vet Intern Med 14:578–582.

214 Forster‐Van Hijfte, M.A., C.F. Curtis, and R.N. White. 1997. Resolution of exfoliative dermatitis and Malassezia pachydermatis overgrowth in a cat after surgical thymoma resection. J Small Anim Pract 38:451–454.

215 Fowler, E.H., G.P. Wilson, and A. Koestner. 1974. Biologic behavior of canine mammary neoplasms based on a histogenetic classification. Vet Pathol 11:212–229.

216 Frazier, S.A., S.M. Johns, J. Ortega, et al. 2012. Outcome in dogs with surgically resected oral fibrosarcoma (1997–2008). Vet Comp Oncol 10:33–43.

217 Freeman, K.P., K.A. Hahn, F.D. Harris, et al. 2003. Treatment of dogs with oral melanoma by hypofractionated radiation therapy and platinum‐based chemotherapy (1987–1997). J Vet Intern Med 17:96–101.

218 Frenais, R., D. Rosenberg, S. Burgaud, et al. 2009. Clinical efficacy and safety of a once‐daily formulation of carbimazole in cats with hyperthyroidism. J Small Anim Pract 50:510–515.

219 Frimberger, A.E., A.S. Moore, S.M. Larue, et al. 1997. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989–1993). J Am Anim Hosp Assoc 33:320–324.

220 Fujiwara, A., T. Kobayashi, Y. Kazato, et al. 2013. Efficacy of hypofractionated radiotherapy for nasal tumours in 38 dogs (2005–2008). J Small Anim Pract 54:80–86.

221 Fukui, S., Y. Endo, K. Hirayama, et al. 2015. Identification and preservation of the parathyroid gland during total thyroidectomy in dogs with bilateral thyroid carcinoma: A report of six cases. J Vet Med Sci 77:747–751.

222 Fulcher, R.P., L.L. Ludwig, P.J. Bergman, et al. 2006. Evaluation of a two‐centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 228:210–215.

223 Gabai, V., F.M. Venanzi, E. Bagashova, et al. 2014. Pilot study of p62 DNA vaccine in dogs with mammary tumors. Oncotarget 5:12803–12810.

224 Gardner, H., J. Fidel, G. Haldorson, et al. 2015a. Canine oral fibrosarcomas: A retrospective analysis of 65 cases (1998‐2010). Vet Comp Oncol 13:40–47.

225 Gardner, H.L., C.A. London, R.A. Portela, et al. 2015b. Maintenance therapy with toceranib following doxorubicin‐based chemotherapy for canine splenic hemangiosarcoma. BMC Vet Res 11:131.

226 Garrett, L.D., D.H. Thamm, R. Chun, et al. 2002. Evaluation of a 6‐month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 16:704–709.

227 Gasch, E.G., P. Rivier, and J.F. Bardet. 2013. Free proximal cortical ulnar autograft for the treatment of distal radial osteosarcoma in a dog. Can Vet J 54:162–166.

228 Gately, S. and R. Kerbel. 2001. Antiangiogenic scheduling of lower dose cancer chemotherapy. Cancer J 7:427–436.

229 Gavazza, A., G. Lubas, A. Fridman, et al. 2013. Safety and efficacy of a genetic vaccine targeting telomerase plus chemotherapy for the therapy of canine B‐cell lymphoma. Hum Gene Ther 24:728–738.

230 Geigy, C., B. Riond, C.R. Bley, et al. 2013. Multiple myeloma in a dog with multiple concurrent infectious diseases and persistent polyclonal gammopathy. Vet Clin Pathol 42:47–54.

231 Gemignani, F, P.D. Mayhew, M.A. Giuffrida, et al. 2018. Association of surgical approach with complication rate, progression‐free survival time, and disease‐specific survival time in cats with mammary adenocarcinoma: 107 cases (1991–2014). J Am Vet Med Assoc 252(11):1393–1402.

232 Gentilini, F., C. Calzolari, A. Buonacucina, et al. 2005. Different biological behaviour of Waldenstrom Macroglobulinemia in two dogs. Vet Comp Oncol 3:87–97.

233 Gerritsen, R.J., E. Teske, J.S. Kraus, et al. 1998. Multi‐agent chemotherapy for mast cell tumours in the dog. Vet Q 20:28–31.

234 Gieger, T.L. and M.W. Nolan. 2018. Linac‐based stereotactic radiation therapy for canine non‐lymphomatous nasal tumours: 29 cases (2013–2016). Vet Comp Oncol. 16(1):E68–E75

235 Gieger, T., K. Rassnick, S. Siegel, et al. 2008. Palliation of clinical signs in 48 dogs with nasal carcinomas treated with coarse‐fraction radiation therapy. J Am Anim Hosp Assoc 44:116–123.

236 Gieger, T., S. Siegel, K. Rosen, et al. 2013. Reirradiation of canine nasal carcinomas treated with coarsely fractionated radiation protocols: 37 cases. J Am Anim Hosp Assoc 49:318–324.

237 Gillem, J., M. Giuffrida, and E. Krick. 2017. Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000–2013). Vet Comp Oncol. 15(2):400–410

238 Gillick, A. and M. Spiegle. 1987. Decarbazine treatment of malignant melanoma in a dog. Can Vet J 28:204.

239 Glasser, S.A., S. Charney, N.G. Dervisis, et al. 2014. Use of an image‐guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors. J Am Anim Hosp Assoc 50:96–104.

240 Goldschmidt, M.H. and C. Zoltowski. 1981. Anal sac gland adenocarcinoma in the dog: 14 cases. J Small Anim Pract 22:119–128.

241 Goldstein, R.E., C. Long, N.C. Swift, et al. 2001. Percutaneous ethanol injection for treatment of unilateral hyperplastic thyroid nodules in cats. J Am Vet Med Assoc 218:1298–1302.

242 Gores, B.R., J. Berg, J.L. Carpenter, et al. 1994. Surgical treatment of thymoma in cats: 12 cases (1987–1992). J Am Vet Med Assoc 204:1782–1785.

243 Gower, K.L., J.M. Liptak, W.T. Culp, et al. 2015. Splenic liposarcoma in dogs: 13 cases (2002–2012). J Am Vet Med Assoc 247:1404–1407.

244 Granov, A.M., A.V. Pavlovskii, D.A. Granov, et al. 2005. Radiopaque oil chemical arterial embolization in treatment of pancreatic cancer. Vestn Ross Akad Med Nauk 8: 16–21.

245 Grant, I.A., C.O. Rodriguez, M.S. Kent, et al. 2008. A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors. J Vet Intern Med 22:388–393.

246 Graves, G.M., D.E. Bjorling, and E. Mahaffey. 1988. Canine hemangiopericytoma: 23 cases (1967–1984). J Am Vet Med Assoc 192:99–102.

247 Green, E.M., W.M. Adams, and L.J. Forrest. 2002. Four fraction palliative radiotherapy for osteosarcoma in 24 dogs. J Am Anim Hosp Assoc 38:445–451.

248 Green, M.L., J.D. Smith, and P.H. Kass. 2011. Surgical versus non‐surgical treatment of feline small intestinal adenocarcinoma and the influence of metastasis on long‐term survival in 18 cats (2000–2007). Can Vet J 52:1101–1105.

249 Greene, S.N. and R.M. Bright. 2008. Insulinoma in a cat. J Small Anim Pract 49:38–40.

250 Greene, S.N., M.D. Lucroy, C.B. Greenberg, et al. 2007. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 231:1056–1060.

251 Greenlee, P.G., D.A. Filippa, F.W. Quimby, et al. 1990. Lymphomas in dogs. A morphologic, immunologic, and clinical study. Cancer 66:480–490.

252 Griessmayr, P.C., M. Gauthier, L.G. Barber, et al. 2007. Mushroom‐derived maitake Petfraction as single agent for the treatment of lymphoma in dogs. J Vet Intern Med 21:1409–1412.

253 Griessmayr, P.C., S.E. Payne, J.E. Winter, et al. 2009. Dacarbazine as single‐agent therapy for relapsed lymphoma in dogs. J Vet Intern Med 23:1227–1231.

254 Griffin, A.M., C.I. Dickie, C.N. Catton, et al. 2015. The influence of time interval between preoperative radiation and surgical resection on the development of wound healing complications in extremity soft tissue sarcoma. Ann Surg Oncol 22:2824–2830.

255 Grosenbaugh, D.A., A.T. Leard, P.J. Bergman, et al. 2011. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor. Am J Vet Res 72:1631–1638.

256 Gualtieri, M., M.G. Monzeglio, and M. Di Giancamillo. 1999a. Oesophageal squamous cell carcinoma in two cats. J Small Anim Pract 40:79–83.

257 Gualtieri, M., M.G. Monzeglio, and E. Scanziani. 1999b. Gastric neoplasia. Vet Clin North Am Small Anim Pract 29:415–440.

258 Guerin, V.J., K.W. Thooft, H.F. L’Eplattenier, et al. 2012. Transitional cell carcinoma involving the ductus deferens in a dog. J Am Vet Med Assoc 240:446–449.

259 Guo, Y., C. Shu, X. Zhou, et al. 2012. High‐dose preoperative fractionated radiotherapy does not affect the patency and healing of eptfe vascular prosthesis after replacement of canine abdominal aorta and inferior vena cava. Eur J Vasc Endovasc Surg 43:460–465.

260 Gustafson, N.R., S.E. Lana, M.N. Mayer, et al. 2004. A preliminary assessment of whole‐body radiotherapy interposed within a chemotherapy protocol for canine lymphoma. Vet Comp Oncol 2:125–131.

261 Gyorffy, S., J.C. Rodriguez‐Lecompte, J.P. Woods, et al. 2005. Bone marrow‐derived dendritic cell vaccination of dogs with naturally occurring melanoma by using human gp100 antigen. J Vet Intern Med 19:56–63.

262 Hafeman, S., C. London, R. Elmslie, et al. 2010. Evaluation of liposomal clodronate for treatment of malignant histiocytosis in dogs. Cancer Immunol Immunother 59:441–452.

263 Hafeman, S.D., D. Varland, and S.W. Dow. 2012. Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells. Vet Comp Oncol 10:44–56.

264 Hahn, N.M., P.L. Bonney, D. Dhawan, et al. 2012. Subcutaneous 5‐azacitidine treatment of naturally occurring canine urothelial carcinoma: A novel epigenetic approach to human urothelial carcinoma drug development. J Urol 187:302–309.

265 Hahn, K.A., L. Bravo, W.H. Adams, et al. 1994. Naturally occurring tumors in dogs as comparative models for cancer therapy research. in vivo 8:133–143.

266 Hahn, K.A., G.K. King, and J.K. Carreras. 2004. Efficacy of radiation therapy for incompletely resected grade‐Iii mast cell tumors in dogs: 31 cases (1987–1998). J Am Vet Med Assoc 224:79–82.

267 Hahn, K.A., D.W. Knapp, R.C. Richardson, et al. 1992. Clinical response of nasal adenocarcinoma to cisplatin chemotherapy in 11 dogs. J Am Vet Med Assoc 200:355–357.

268 Hahn, K.A., A.M. Legendre, N.G. Shaw, et al. 2010. Evaluation of 12‐ and 24‐month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors. Am J Vet Res 71:1354–1361.

269 Hahn, K.A., G. Ogilvie, T. Rusk, et al. 2008. Masitinib is safe and effective for the treatment of canine mast cell tumors. J Vet Intern Med 22:1301–1309.

270 Hajduch, M., Z. Kolar, R. Novotny, et al. 1997. Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin‐dependent kinase inhibitor olomoucine. Anticancer Drugs 8:1007–1013.

271 Halle, M., I. Bodin, P. Tornvall, et al. 2009. Timing of radiotherapy in head and neck free flap reconstruction – A study of postoperative complications. J Plast Reconstr Aesthet Surg 62:889–895.

272 Hammer, A.S., C.G. Couto, R.D. Ayl, et al. 1994. Treatment of tumor‐bearing dogs with actinomycin D. J Vet Intern Med 8:236–239.

273 Hammer, A.S., C.G. Couto, J. Filppi, et al. 1991. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Intern Med 5:160–166.

274 Hammer, A., D. Getzy, G. Ogilvie, et al. 2001. Salivary gland neoplasia in the dog and cat: Survival times and prognostic factors. J Am Anim Hosp Assoc 37:478–482.

275 Hanna, F. 2005. Multiple myelomas in cats. J Feline Med Surg 7:275–287.

276 Hansen, K.S., C. Weisse, A.C. Berent, et al. 2012. Use of a self‐expanding metallic stent to palliate esophageal neoplastic obstruction in a dog. J Am Vet Med Assoc 240:1202–1207.

277 Hardie, E.M., J.A. Barsanti, and C. Rawlings. 1984. Complications of prostatic surgery. J Am Anim Hosp Assoc 20:50–56.

278 Hargis, A.M., P.J. Ihrke, W.L. Spangler, et al. 1992. A retrospective clinicopathologic study of 212 dogs with cutaneous hemangiomas and hemangiosarcomas. Vet Pathol 29:316–328.

279 Harvey, H.J., E.G. Macewen, D. Braun, et al. 1981. Prognostic criteria for dogs with oral melanoma. J Am Vet Med Assoc 178:580–582.

280 Hasinoff, B.B. 2006. Dexrazoxane use in the prevention of anthracycline extravasation injury. Future Oncol 2:15–20.

281 Havlicek, M., R.S. Straw, V. Langova, et al. 2009. Intra‐operative cisplatin for the treatment of canine extremity soft tissue sarcomas. Vet Comp Oncol 7:122–129.

282 Hayashi, A., H. Tanaka, T. Tajima, et al. 2013. A spayed female cat with squamous cell carcinoma in the uterine remnant. J Vet Med Sci 75:391–393.

283 Heidner, G.L., R.L. Page, M.C. McEntee, et al. 1991. Treatment of canine appendicular osteosarcoma using cobalt 60 radiation and intraarterial cisplatin. J Vet Intern Med 5:313–316.

284 Heller, D.A., M.E. Stebbins, T.L. Reynolds, et al. 2005. A retrospective study of 87 cases of canine soft tissue sarcomas, 1986–2001. Int J Appl Res Vet Med 3:81–87.

285 Henry, C.J., D.L. Mccaw, S.E. Turnquist, et al. 2003. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin Cancer Res 9:906–911.

286 Hermo, G.A., P. Torres, G.V. Ripoll, et al. 2008. Perioperative desmopressin prolongs survival in surgically treated bitches with mammary gland tumours: A pilot study. Vet J 178:103–108.

287 Hermo, G.A., E. Turic, D. Angelico, et al. 2011. Effect of adjuvant perioperative desmopressin in locally advanced canine mammary carcinoma and its relation to histologic grade. J Am Anim Hosp Assoc 47:21–27.

288 Hershey, A.E., I.D. Kurzman, L.J. Forrest, et al. 1999. Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: Proof of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res 5:2653–2659.

289 Hershey, A.E., K.U. Sorenmo, M.J. Hendrick, et al. 2000. Prognosis for presumed feline vaccine‐associated sarcoma after excision: 61 cases (1986–1996). J Am Vet Med Assoc 216:58–61.

290 Higginbotham, M.L., D.L. McCaw, J.K. Roush, et al. 2013. Intermittent single‐agent doxorubicin for the treatment of canine B‐cell lymphoma. J Am Anim Hosp Assoc 49:357–362.

291 Higgs, P. and A. Hibbert. 2012. Managing hyperthyroidism in cats. Vet Rec 171:225–226.

292 Higuchi, T., G.N. Burcham, M.O. Childress, et al. 2013. Characterization and treatment of transitional cell carcinoma of the abdominal wall in dogs: 24 cases (1985–2010). J Am Vet Med Assoc 242:499–506.

293 Higuchi, T., N. Dervisis, and B.E. Kitchell. 2010. Efficacy of doxorubicin for histiocytic sarcoma in dogs. In Proceedings of the Veterinary Cancer Society, 30th Annual Conference. San Diego, USA, October 29–November 1, 2010, p. 51.

294 Hill, K.E., J.P. Chambers, B.R. Jones, et al. 2015a. Regional variations in percutaneous absorption of methimazole: An in vitro study on cat skin. J Vet Pharmacol Ther 38:616–618.

295 Hill, K.E., J.P. Chambers, B.R. Jones, et al. 2015b. Trans‐pinnal movement of methimazole: An in vitro study showing that methimazole can cross from the inner to outer pinna of cats. J Feline Med Surg 17:1005–1011.

296 Hill, K.E., M.A. Gieseg, D. Kingsbury, et al. 2011. The efficacy and safety of a novel lipophilic formulation of methimazole for the once daily transdermal treatment of cats with hyperthyroidism. J Vet Intern Med 25:1357–1365.

297 Hill, K.E., P.C. Mills, B.R. Jones, et al. 2015c. Percutaneous absorption of methimazole: An in vitro study of the absorption pharmacokinetics for two different vehicles. J Vet Pharmacol Ther 38:581–589.

298 Hillers, K.R., S.E. Lana, C.R. Fuller, et al. 2007. Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs. J Am Anim Hosp Assoc 43:187–192.

299 Hitt, M.E., D.P. Shaw, P.M. Hogan, et al. 1987. Radiation treatment for thymoma in a dog. J Am Vet Med Assoc 190:1187–1190.

300 Hobson, H.P., M.R. Brown, and K.S. Rogers. 2006. Surgery of metastatic anal sac adenocarcinoma in five dogs. Vet Surg 35:267–270.

301 Hodge, S.C., D. Degner, R. Walshaw, et al. 2011. Vascularized ulnar bone grafts for limb‐sparing surgery for the treatment of distal radial osteosarcoma. J Am Anim Hosp Assoc 47:98–111.

302 Hoelzler, M.G., J.R. Bellah, and M.C. Donofro. 2001. Omentalization of cystic sublumbar lymph node metastases for long‐term palliation of tenesmus and dysuria in a dog with anal sac adenocarcinoma. J Am Vet Med Assoc 219:1729–1731, 1708.

303 Hoffman, S.B., A.R. Yoder, and L.A. Trepanier. 2002. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. J Vet Pharmacol Ther 25:189–193.

304 Hoffmann, G., S.L. Marks, J. Taboada, et al. 2003. Transdermal methimazole treatment in cats with hyperthyroidism. J Feline Med Surg 5:77–82.

305 Hogge, G.S., J.K. Burkholder, J. Culp, et al. 1999. Preclinical development of human granulocyte‐macrophage colony‐stimulating factor‐transfected melanoma cell vaccine using established canine cell lines and normal dogs. Cancer Gene Ther 6:26–36.

306 Holt, P.E. 2007. Evaluation of transanal endoscopic treatment of benign canine rectal neoplasia. J Small Anim Pract 48:17–25.

307 Holt, P.E. and P. Durdey. 1999. Transanal endoscopic treatment of benign canine rectal tumours: Preliminary results in six cases (1992 to 1996). J Small Anim Pract 40:423–427.

308 Holtermann, N., M. Kiupel, M. Kessler, et al. 2016. Masitinib monotherapy in canine epitheliotropic lymphoma. Vet Comp Oncol 14 (Suppl 1):127–135.

309 Huber, D.J., S.J. Withrow, S.M. Larue, et al. 2000. Limb sparing with intraoperative radiation for bone sarcomas. Vet Surg 29:446–456.

310 Hui, T.Y., D.S. Bruyette, G.E. Moore, et al. 2015. Effect of feeding an iodine‐restricted diet in cats with spontaneous hyperthyroidism. J Vet Intern Med 29:1063–1068.

311 Hunley, D.W., G.N. Mauldin, K. Shiomitsu, et al. 2010. Clinical outcome in dogs with nasal tumors treated with intensity‐modulated radiation therapy. Can Vet J 51:293–300.

312 Irvine‐Smith, G.S. and R.G. Lobetti. 2006. Ipsilateral vascularised ulnar transposition autograft for limb‐sparing surgery of the distal radius in 2 dogs with osteosarcoma. J S Afr Vet Assoc 77:150–154.

313 Isidoro‐Ayza, M., A. Lloret, M. Bardagi, et al. 2014. Superficial necrolytic dermatitis in a dog with an insulin‐producing pancreatic islet cell carcinoma. Vet Pathol 51:805–808.

314 Itoh, T., K. Mikawa, M. Mikawa, et al. 2004. Lymphangiosarcoma in a dog treated with surgery and chemotherapy. J Vet Med Sci 66:197–199.

315 Itoh, H., T. Mukaiyama, T. Goto, et al. 2014. Non‐surgical treatment of canine oral malignant melanoma: A case study of the application of complementary alternative medicine. Oncol Lett 7:1829–1830.

316 Jackson, J., K.P. Richter, and D.P. Launer. 1999. Thoracoscopic partial pericardiectomy in 13 dogs. J Vet Intern Med 13:529–533.

317 Jacobs, T.M. and G.M. Rosen. 2000. Photodynamic therapy as a treatment for esophageal squamous cell carcinoma in a dog. J Am Anim Hosp Assoc 36:257–261.

318 Jeglum, K.A. 1996. Chemoimmunotherapy of canine lymphoma with adjuvant canine monoclonal antibody 231. Vet Clin North Am Small Anim Pract 26:73–85.

319 Jeglum, K.A., A. Whereat, and K. Young. 1983. Chemotherapy of canine thyroid carcinoma. Compend Contin Educ Pract Vet 5:96–98.

320 Jeglum, K.A., K.M. Young, K. Barnsley, et al. 1988. Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma. Cancer 61:2042–2050.

321 Jourdier, T.M., C. Moste, M.C. Bonnet, et al. 2003. Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2). Gene Ther 10:2126–2132.

322 Kahn, S.A., C.M. Mullin, L.P. De Lorimier, et al. 2013. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: A pilot study. Can Vet J 54:237–242.

323 Kane, R.C., W.D. McGuinnJr., R. Dagher, et al. 2008. Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy. Oncologist 13:445–450.

324 Karayannopoulou, M., E. Kaldrymidou, T.C. Constantinidis, et al. 2001. Adjuvant post‐operative chemotherapy in bitches with mammary cancer. J Vet Med A Physiol Pathol Clin Med 48:85–96.

325 Kaser‐Hotz, B., C.R. Rohrer, J.L. Fidel, et al. 2001. Radiotherapy in three suspect cases of feline thymoma. J Am Anim Hosp Assoc 37:483–488.

326 Kawabe, M., T. Mori, Y. Ito, et al. 2015. Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases (2006–2012). J Am Vet Med Assoc 247:1146–1153.

327 Keller, E.T., E.G. MacEwen, R.C. Rosenthal, et al. 1993. Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma. J Vet Intern Med 7:289–295.

328 Kent, E.M. 1993. Use of an immunostimulant as an aid in treatment and management of fibrosarcoma in three cats. Fel Pract 21:13.

329 Kent, M.S., A. Strom, and C.A. London. et al. 2004. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb‐sparing surgery in the treatment of appendicular osteosarcoma in dogs. J Vet Intern Med 18:540–544.

330 Kerstetter, K.K., D.J. KrahwinkelJr., D.L. Millis, et al. 1997. Pericardiectomy in dogs: 22 cases (1978–1994). J Am Vet Med Assoc 211:736–740.

331 Keyerleber, M.A., T.L. Gieger, H.N. Erb, et al. 2012. Three‐dimensional conformal versus non‐graphic radiation treatment planning for apocrine gland adenocarcinoma of the anal sac in 18 dogs (2002–2007). Vet Comp Oncol 10:237–245.

332 Khanna, C., E.M. Lund, K.A. Redic, et al. 1998. Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma. J Am Vet Med Assoc 213:985–990.

333 Kim, C., A. Matsuyama, A.J. Mutsaers, et al. 2017. Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma. Can Vet J 58:1059–1064.

334 Kim, H., M. Nakaichi, K. Itamoto, et al. 2008. Malignant mixed tumor in the salivary gland of a cat. J Vet Sci 9:331–333.

335 King, G.K., K.M. Yates, P.M. Greenlace, et al. 1995. The effect of acemannan immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas. J Am Anim Hosp Assoc 31:439–447.

336 Kirpensteijn, J., R.C. Straw, A.D. Pardo, et al. 1994. Partial and total scapulectomy in the dog. J Am Anim Hosp Assoc 30:313–319.

337 Kishimoto, T.E., H. Yoshimura, N. Saito, et al. 2015. Salivary gland epithelial‐myoepithelial carcinoma with high‐grade transformation in a dog. J Comp Pathol 153:111–115.

338 Kitchell, B.E., D.M. Brown, E.E. Luck, et al. 1994. Intralesional implant for treatment of primary oral malignant melanoma in dogs. J Am Vet Med Assoc 204:229–236.

339 Kiupel, M., J.D. Webster, K.L. Bailey, et al. 2011. Proposal of a 2‐tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Vet Pathol 48:147–155.

340 Kiupel, M., J.D. Webster, R.A. Miller, et al. 2005. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. J Vet Med A Physiol Pathol Clin Med 52:280–286.

341 Klahn, S.L., B.E. Kitchell, and N.G. Dervisis. 2011. Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma. J Am Vet Med Assoc 239:90–96.

342 Klein, M.K., B.E. Powers, S.J. Withrow, et al. 1995. Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981–1989). J Am Vet Med Assoc 206:1007–1009.

343 Klueter, S., D. Krastel, E. Ludewig, et al. 2006. High‐dose‐rate brachytherapy for intranasal tumours in dogs: Results of a pilot study. Vet Comp Oncol 4:218–231.

344 Knapp, D.W., C.J. Henry, W.R. Widmer, et al. 2013. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 27:126–133.

345 Knapp, D.W., R.C. Richardson, T.C. Chan, et al. 1994. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 8:273–278.

346 Knottenbelt, C.M., J.W. Simpson, S. Tasker, et al. 2000. Preliminary clinical observations on the use of piroxicam in the management of rectal tubulopapillary polyps. J Small Anim Pract 41:393–397.

347 Kobayashi, T., M.L. Hauck, R. Dodge, et al. 2002. Preoperative radiotherapy for vaccine associated sarcoma in 92 cats. Vet Radiol Ultrasound 43:473–479.

348 Kodre, V., M. Cemazar, J. Pecar, et al. 2009. Electrochemotherapy compared to surgery for treatment of canine mast cell tumors. in vivo 23:55–62.

349 Kolb, B.A., R.E. Buller, J.P. Connor, et al. 1992. Effects of early postoperative chemotherapy on wound healing. Obstet Gynecol 79:988–992.

350 Konietschke, U., E. Teske, K. Jurina, et al. 2012. Palliative intralesional interleukin‐2 treatment in dogs with urinary bladder and urethral carcinomas. in vivo 26:931–935.

351 Kosovsky, J.K., D.T. Matthiesen, S.M. Marretta, et al. 1991. Results of partial mandibulectomy for the treatment of oral tumors in 142 dogs. Vet Surg 20:397–401.

352 Kosovsky, J.E., D.T. Matthiesen, and A.K. Patnaik. 1988. Small intestinal adenocarcinoma in cats: 32 cases (1978–1985). J Am Vet Med Assoc 192:233–235.

353 Kozicki, A.R., C. Robat, R. Chun, et al. 2015. Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma. Vet Comp Oncol 13:229–236.

354 Kraje, A.C., E.A. Mears, K.A. Hahn, et al. 1999. Unusual metastatic behavior and clinicopathologic findings in eight cats with cutaneous or visceral hemangiosarcoma. J Am Vet Med Assoc 214:670–672.

355 Kramek, B.A., J.A. Spackman, and D.W. Hayden. 1985. Infiltrative lipoma in three dogs. J Am Vet Med Assoc 186:81–82.

356 Kramer, R.W., G.S. Price, and G.J. Spodnick. 1994. Hypothyroidism in a dog after surgery and radiation‐therapy for a functional thyroid adenocarcinoma. Vet Radiol Ultrasound 35:132–136.

357 Kry, K.L. and S.E. Boston. 2014. Additional local therapy with primary re‐excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs. Vet Surg 43:182–189.

358 Kryiazidou, A., P.J. Brown, and V.M. Lucke. 1989. Immunohistochemical staining of neoplastic and inflammatory plasma cell lesions in feline tissues. J Comp Pathol 100:337–341.

359 Kubicek, L., D. Vanderhart, K. Wirth, et al. 2016. Association between computed tomographic characteristics and fractures following stereotactic radiosurgery in dogs with appendicular osteosarcoma. Vet Radiol Ultrasound 57:321–330.

360 Kudnig, S.T., N. Ehrhart, S.J. Withrow, et al. 2003. Survival analysis of oral melanoma in dogs. In Proceedings of the 23rd Annual Conference of the Veterinary Cancer Society, Madison, WI, 22:39.

361 Kumagai, D., T. Shimada, J. Yamate, et al. 2003. Use of an incontinent end‐on colostomy in a dog with annular rectal adenocarcinoma. J Small Anim Pract 44:363–366.

362 Kung, M.B., V.J. Poirier, M.M. Dennis, et al. 2016. Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma. Vet Comp Oncol 14(4):e135–e145

363 Kuntz, C.A., T.L. Asselin, W.S. Dernell, et al. 1998. Limb salvage surgery for osteosarcoma of the proximal humerus: Outcome in 17 dogs. Vet Surg 27:417–422.

364 Kuntz, C.A., W.S. Dernell, B.E. Powers, et al. 1997. Prognostic factors for surgical treatment of soft‐tissue sarcomas in dogs: 75 cases (1986–1996). J Am Vet Med Assoc 211:1147–1151.

365 Ladue, T.A., R. Dodge, R.L. Page, et al. 1999. Factors influencing survival after radiotherapy of nasal tumors in 130 dogs. Vet Radiol Ultrasound 40:312–317.

366 Ladue, T., G.S. Price, R. Dodge, et al. 1998. Radiation therapy for incompletely resected canine mast cell tumors. Vet Radiol Ultrasound 39:57–62.

367 Lana, S.E., W.S. Dernell, M.H. Lafferty, et al. 2004. Use of radiation and a slow‐release cisplatin formulation for treatment of canine nasal tumors. Vet Radiol Ultrasound 45:577–581.

368 Lana, S.E., W.S. Dernell, S.M. Larue, et al. 1997. Slow release cisplatin combined with radiation for the treatment of canine nasal tumors. Vet Radiol Ultrasound 38:474–478.

369 Lana, S., L. U'ren, S. Plaza, et al. 2007. Continuous low‐dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs. J Vet Intern Med 21:764–769.

370 Lane, A., M. Black, and K. Wyatt. 2012. Toxicity and efficacy of a novel doxorubicin and carboplatin chemotherapy protocol for the treatment of canine appendicular osteosarcoma following limb amputation. Aust Vet J 90:69–74.

371 Langer, S.W., A.V. Thougaard, M. Sehested, et al. 2006. Treatment of anthracycline extravasation in mice with dexrazoxane with or without Dmso and hydrocortisone. Cancer Chemother Pharmacol 57:125–128.

372 Langova, V., A.J. Mutsaers, B. Phillips, et al. 2004. Treatment of eight dogs with nasal tumours with alternating doses of doxorubicin and carboplatin in conjunction with oral piroxicam. Aust Vet J 82:676–680.

373 Larue, S.M. and I.K. Gordon. 2013. 12 – Radiation therapy. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.

374 Larue, S.M., S.J. Withrow, B.E. Powers, et al. 1989. Limb‐sparing treatment for osteosarcoma in dogs. J Am Vet Med Assoc 195:1734–1744.

375 Lascelles, B.D., R.A. Henderson, B. Seguin, et al. 2004. Bilateral rostral maxillectomy and nasal planectomy for large rostral maxillofacial neoplasms in six dogs and one cat. J Am Anim Hosp Assoc 40:137–146.

376 Lascelles, B.D., M.J. Thomson, W.S. Dernell, et al. 2003. Combined dorsolateral and intraoral approach for the resection of tumors of the maxilla in the dog. J Am Anim Hosp Assoc 39:294–305.

377 Lavalle, G.E., C.B. De Campos, A.C. Bertagnolli, et al. 2012. Canine malignant mammary gland neoplasms with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors. in vivo 26:375–379.

378 Laver, T., B.R. Feldhaeusser, C.S. Robat, et al. 2018a. Post‐surgical outcome and prognostic factors in canine malignant melanomas of the haired skin: 87 cases (2003–2015). Can Vet J 59(9):981–987.

379 Laver, T., C.A. London, D.M. Vail, et al. 2018b. Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma. Vet Comp Oncol 16(1):E23–E29.

380 Lawrence, J.A., L.J. Forrest, M.M. Turek, et al. 2010. Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity‐modulated radiation therapy. Vet Radiol Ultrasound 51:561–570.

381 Leach, T.N., M.O. Childress, S.N. Greene, et al. 2012. Prospective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancer. Vet Comp Oncol 10:102–112.

382 Leav, I., A.L. Schiller, A. Rijnberk, et al. 1976. Adenomas and carcinomas of the canine and feline thyroid. Am J Pathol 83:61–122.

383 Lecuyer, M., S. Prini, M.E. Dunn, et al. 2006. Clinical efficacy and safety of transdermal methimazole in the treatment of feline hyperthyroidism. Can Vet J 47:131–135.

384 Lee, H.C., J.H. Kim, C.H. Jee, et al. 2014. A case of gastric adenocarcinoma in a Shih Tzu dog: Successful treatment of early gastric cancer. J Vet Med Sci 76:1033–1038.

385 Leifer, C.E., M.E. Peterson, and R.E. Matus. 1986. Insulin‐secreting tumor: Diagnosis and medical and surgical management in 55 dogs. J Am Vet Med Assoc 188:60–64.

386 Lejeune, A., K. Skorupski, S. Frazier, et al. 2015. Aggressive local therapy combined with systemic chemotherapy provides long‐term control in grade II stage 2 canine mast cell tumour: 21 cases (1999–2012). Vet Comp Oncol 13:267–280.

387 Lengerich, E.J., R.F. Teclaw, J.M. Mendlein, et al. 1992. Pet populations in the catchment area of the Purdue Comparative Oncology Program. J Am Vet Med Assoc 200:51–56.

388 L’Eplattenier H.F., B. Klem, E. Teske, et al. 2008. Preliminary results of intraoperative photodynamic therapy with 5‐aminolevulinic acid in dogs with prostate carcinoma. Vet J 178:202–207.

389 L’Eplattenier, H.F., S.A. Van Nimwegen, F.J. Van Sluijs, et al. 2006. Partial prostatectomy using Nd:Yag laser for management of canine prostate carcinoma. Vet Surg 35:406–411.

390 Liao, A.T., M.B. Chien, N. Shenoy, et al. 2002. Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors. Blood 100:585–593.

391 Lidbetter, D.A., F.A. WilliamsJr., D.J. Krahwinkel, et al. 2002. Radical lateral body‐wall resection for fibrosarcoma with reconstruction using polypropylene mesh and a caudal superficial epigastric axial pattern flap: A prospective clinical study of the technique and results in 6 cats. Vet Surg 31:57–64.

392 Liptak, J.M. and N.S. Brebner. 2006. Hemidiaphragmatic reconstruction with a transversus abdominis muscle flap after resection of a solitary diaphragmatic mesothelioma in a dog. J Am Vet Med Assoc 228:1204–1208.

393 Liptak, J.M., S.P. Brutscher, E. Monnet, et al. 2004a. Transurethral resection in the management of urethral and prostatic neoplasia in 6 dogs. Vet Surg 33:505–516.

394 Liptak, J.M., W.S. Dernell, N. Ehrhart, et al. 2006. Cortical allograft and endoprosthesis for limb‐sparing surgery in dogs with distal radial osteosarcoma: A prospective clinical comparison of two different limb‐sparing techniques. Vet Surg 35:518–533.

395 Liptak, J.M., W.S. Dernell, B.D. Lascelles, et al. 2004b. Intraoperative extracorporeal irradiation for limb sparing in 13 dogs. Vet Surg 33:446–456.

396 Liptak, J.M. and L.J. Forrest. 2013. 21 – soft tissue sarcomas. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.

397 Liptak, J.M., G.E. Pluhar, W.S. Dernell, et al. 2005. Limb‐sparing surgery in a dog with osteosarcoma of the proximal femur. Vet Surg 34:71–77.

398 Little, C.J., G.R. Pearson, and J.G. Lane. 1989. Neoplasia involving the middle ear cavity of dogs. Vet Rec 124:54–57.

399 Lombardi, P., S. Florio, U. Pagnini, et al. 1999. Ovarian function suppression with a GnRH analogue: D‐ser(But[t])[6]‐Arzgly[10]‐Lhrh (Goserelin) in hormone dependent canine mammary cancer. J Vet Pharmacol Ther 22:56–61.

400 London, C.A., R.R. Dubilzeig, D.M. Vail, et al. 1996. Evaluation of dogs and cats with tumors of the ear canal: 145 cases (1978–1992). J Am Vet Med Assoc 208:1413–1418.

401 London, C.A., H.L. Gardner, T. Mathie, et al. 2015. Impact of toceranib/piroxicam/cyclophosphamide maintenance therapy on outcome of dogs with appendicular osteosarcoma following amputation and carboplatin chemotherapy: A multi‐institutional study. PLoS One 10:e0124889.

402 London, C.A., A.L. Hannah, R. Zadovoskaya, et al. 2003. Phase I dose‐escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clin Cancer Res 9:2755–2768.

403 London, C.A., P.B. Malpas, S.L. Wood‐Follis, et al. 2009. Multi‐center, placebo‐controlled, double‐blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision. Clin Cancer Res 15:3856–3865.

404 London, C., T.Mathie, N.Stingle et al. 2012. Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours. Vet Comp Oncol 10(3):194–205.

405 Lori, J.C., T.J. Stein, and D.H. Thamm. 2010. Doxorubicin and cyclophosphamide for the treatment of canine lymphoma: A randomized, placebo‐controlled study. Vet Comp Oncol 8:188–195.

406 Lucas, S.R., R.C. Maranhao, J.L. Guerra, et al. 2015. Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma. Vet Comp Oncol 13:184–193.

407 Lucroy, M.D., M.H. Bowles, R.G. Higbee, et al. 2003a. Photodynamic therapy for prostatic carcinoma in a dog. J Vet Intern Med 17:235–237.

408 Lucroy, M.D., K.R. Long, M.A. Blaik, et al. 2003b. Photodynamic therapy for the treatment of intranasal tumors in 3 dogs and 1 cat. J Vet Intern Med 17:727–729.

409 Lucroy, M.D., T.D. Ridgway, G.M. Peavy, et al. 2003c. Preclinical evaluation of 5‐aminolevulinic acid‐based photodynamic therapy for canine transitional cell carcinoma. Vet Comp Oncol 1:76–85.

410 Lunn, K.F. and R.L. Page. 2013. 25 – Tumors of the endocrine system. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.

411 Lurie, D.M., I.K. Gordon, A.P. Theon, et al. 2009. Sequential low‐dose rate half‐body irradiation and chemotherapy for the treatment of canine multicentric lymphoma. J Vet Intern Med 23:1064–1070.

412 MacDonald, T.L. and T.D. Schiller. 2010. Limb‐sparing surgery using tantalum metal endoprosthesis in a dog with osteosarcoma of the distal radius. Can Vet J 51:497–500.

413 MacEwan, E.P., B.E. Powers, and D. Macy. 2001. Soft tissue sarcomas. In Small Animal Clinical Oncology, 3rd edition. S.J. Withrow, editor. Philadelphia: WB Saunders.

414 MacEwen, E.G., N.O. Brown, A.K. Patnaik, et al. 1981. Cyclic combination chemotherapy of canine lymphosarcoma. J Am Vet Med Assoc 178:1178–1181.

415 MacEwen, E.G., A.A. Hayes, R.E. Matus, et al. 1987. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978–1981). J Am Vet Med Assoc 190:564–568.

416 MacEwen, E.G., A.A. Hayes, S. Mooney, et al. 1985. Levamisole as adjuvant to chemotherapy for canine lymphosarcoma. J Biol Response Mod 4:427–433.

417 MacEwen, E.G. and A.I. Hurvitz. 1977. Diagnosis and management of monoclonal gammopathies. Vet Clin North Am 7:119–132.

418 MacEwen, E.G., I.D. Kurzman, D.M. Vail, et al. 1999. Adjuvant therapy for melanoma in dogs: Results of randomised clinical trials using surgery, liposome‐encapsulated muramyl tripeptide and granulocyte‐macrophage colony‐stimulating factor. Clin Cancer Res 5:42–49.

419 MacEwen, E.G., A.K. Patnaik, H.J. Harvey, et al. 1986. Canine oral melanoma: Comparison of surgery versus surgery plus Corynebacterium parvum. Cancer Invest 4:397–402.

420 Macewen, E.G., A.K. Patnaik, A.I. Hurvitz, et al. 1984. Nonsecretory multiple myeloma in two dogs. J Am Vet Med Assoc 184:1283–1286.

421 MacEwen, E.G., S.J. Withrow, and A.K. Patnaik. 1977. Nasal tumors in the dog: Retrospective evaluation of diagnosis, prognosis, and treatment. J Am Vet Med Assoc 170:45–48.

422 Macy, D.W. 1986. Canine and feline mast cell tumors: Biologic behavior, diagnosis, and therapy. Semin Vet Med Surg Small Anim 1:72–83.

423 Maglennon, G.A., S. Murphy, V. Adams, et al. 2008. Association of Ki67 index with prognosis for intermediate‐grade canine cutaneous mast cell tumours. Vet Comp Oncol 6:268–274.

424 Mahoney, J.A., P.J. Bergman, M.A. Camps‐Palau, et al. 2007. Treatment of doxorubicin extravasation with intravenous dexrazoxane in a cat. J Vet Intern Med 21:872–873.

425 Mallery, K.F., R.E. Pollard, R.W. Nelson, et al. 2003. Percutaneous ultrasound‐guided radiofrequency heat ablation for treatment of hyperthyroidism in cats. J Am Vet Med Assoc 223:1602–1607.

426 Marcinowska, A., J. Warland, M. Brearley, et al. 2013. A novel approach to treatment of lymphangiosarcoma in a boxer dog. J Small Anim Pract 54:334–337.

427 Marconato, L., P. Frayssinet, N. Rouquet, et al. 2014. Randomized, placebo‐controlled, double‐blinded chemoimmunotherapy clinical trial in a pet dog model of diffuse large B‐cell lymphoma. Clin Cancer Res 20:668–677.

428 Marconato, L., R.M. Lorenzo, F. Abramo, et al. 2008. Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs. Vet Comp Oncol 6:90–101.

429 Marconato, L., V. Martini, D. Stefanello, et al. 2015a. Peripheral blood lymphocyte/monocyte ratio as a useful prognostic factor in dogs with diffuse large B‐cell lymphoma receiving chemoimmunotherapy. Vet J 206:226–230.

430 Marconato, L., D.B. Nitzl, K.J. Melzer‐Ruess, et al. 2012. Chemotherapy and radiation therapy in 4 dogs with muscle‐invasive transitional cell carcinoma of the urinary tract. Can Vet J 53:875–879.

431 Marconato, L., D. Stefanello, S. Sabattini, et al. 2015b. Enhanced therapeutic effect of Apavac immunotherapy in combination with dose‐intense chemotherapy in dogs with advanced indolent B‐cell lymphoma. Vaccine 33:5080–5086.

432 Marconato, L., E. Zini, D. Lindner, et al. 2011. Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 238:1004–1010.

433 Marino, D.J., J.M. MacDonald, D.T. Matthiesen, et al. 1993. Results of surgery and long‐term follow‐up in dogs with ceruminous gland adenocarcinoma. J Am Anim Hosp Assoc 29:560–563.

434 Marino, D.J., J.M. MacDonald, D.T. Matthiesen, et al. 1994. Results of surgery in cats with ceruminous gland adenocarcinoma. J Am Anim Hosp Assoc 30:54–58.

435 Marks, S. 2001. Update on canine and feline gastrointestinal neoplasia. In 26th World Small Animal Veterinary Association World Congress, Vancouver, BC.

436 Martin, R.A., E.W. Evans, J.R. August, et al. 1986. Surgical treatment of a thymoma in a cat. J Am Anim Hosp Assoc 22:347–354.

437 Maruo, T., T. Shida, Y. Fukuyama, et al. 2011. Retrospective study of canine nasal tumor treated with hypofractionated radiotherapy. J Vet Med Sci 73:193–197.

438 Marvel, S.J., B. Seguin, D.D. Dailey, et al. 2017. Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder. Vet Comp Oncol 15:1417–1427.

439 Matsuyama, A., C.R. Schott, G.A. Wood, et al. 2018. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy. J Am Vet Med Assoc 252(11):1377–1383.

440 Matus, R.E., C.E. Leifer, E.G. MacEwen, et al. 1986. Prognostic factors for multiple myeloma in the dog. J Am Vet Med Assoc 188:1288–1292.

441 Mauldin, G.N., R.E. Matus, A.K. Patnaik, et al. 1988a. Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats. J Vet Intern Med 2:60–65.

442 Mauldin, G.N., R.E. Matus, S.J. Withrow, et al. 1988b. Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin. J Vet Intern Med 2:177–180.

443 Mayhew, P.D., G.B. Hunt, M.A. Steffey, et al. 2013. Evaluation of short‐term outcome after lung lobectomy for resection of primary lung tumors via video‐assisted thoracoscopic surgery or open thoracotomy in medium‐ to large‐breed dogs. J Am Vet Med Assoc 243:681–688.

444 McAbee, K.P., L.L. Ludwig, P.J. Bergman, et al. 2005. Feline cutaneous hemangiosarcoma: A retrospective study of 18 cases (1998–2003). J Am Anim Hosp Assoc 41:110–116.

445 McCaw, D.L., M.A. Miller, P.J. Bergman, et al. 1997. Vincristine therapy for mast cell tumors in dogs. J Vet Intern Med 11:375–378.

446 McChesney, A.E., L.C. Stephens, J. Lebel, et al. 1980. Infiltrative lipoma in dogs. Vet Pathol 17:316–322.

447 McEntee, M.C. and R.L. Page. 2001. Feline vaccine‐associated sarcomas. J Vet Intern Med 15:176–182.

448 McEntee, M.C., R.L. Page, G.N. Mauldin, et al. 2000. Results of irradiation of infiltrative lipoma in 13 dogs. Vet Radiol Ultrasound 41:554–556.

449 McEntee, M.C., R.L. Page, and C.A. Novotney. 1993. Palliative radiotherapy for canine appendicular osteosarcoma. Vet Radiol Ultrasound 34:367–370.

450 McEntee, M.C., V.F. Samii, P. Walsh, et al. 2004. Postoperative assessment of surgical clip position in 16 dogs with cancer: a pilot study. J Am Anim Hosp Assoc 40(4):300–308.

451 McEntee, M.C., M. Steffey, and N.L. Dykes. 2008. Use of surgical hemoclips in radiation treatment planning. Vet Radiol Ultrasound 49:395–399.

452 McKnight, J.A., G.N. Mauldin, M.C. McEntee, et al. 2000. Radiation treatment for incompletely resected soft‐tissue sarcomas in dogs. J Am Vet Med Assoc 217:205–210.

453 McLean, J.L. and R.G. Lobetti. 2015. Use of the melanoma vaccine in 38 dogs: The South African experience. J S Afr Vet Assoc 86:1246.

454 McMahon, M., T. Mathie, N. Stingle, et al. 2011. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma. J Vet Intern Med 25:511–517.

455 McMillan, S.K., P. Boria, G.E. Moore, et al. 2011. Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 239:1084–1089.

456 McMillan, S.K., D.W. Knapp, J.A. Ramos‐Vara, et al. 2012. Outcome of urethral stent placement for management of urethral obstruction secondary to transitional cell carcinoma in dogs: 19 cases (2007–2010). J Am Vet Med Assoc 241:1627–1632.

457 McNeill, C.J., K.U. Sorenmo, F.S. Shofer, et al. 2009. Evaluation of adjuvant doxorubicin‐based chemotherapy for the treatment of feline mammary carcinoma. J Vet Intern Med 23:123–129.

458 McQuown, B., M.A. Keyerleber, K. Rosen, et al. 2017. Treatment of advanced canine anal sac adenocarcinoma with hypofractionated radiation therapy: 77 cases (1999–2013). Vet Comp Oncol 15:840–851.

459 McSporran, K.D. 2009. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas. Vet Pathol 46:928–933.

460 Meier, V., C. Geigy, N. Grosse, et al. 2013. Use of epothilone B (patupilone) in refractory lymphoma and advanced solid tumors in dogs. J Vet Intern Med 27:120–125.

461 Meis, J.M., J.J. Butler, B.M. Osborne, et al. 1987. Solitary plasmacytomas of bone and extramedullary plasmacytomas. A clinicopathologic and immunohistochemical study. Cancer 59:1475–1485.

462 Melendez, L.M., R.M. Yamka, and P.A. Burris. 2011a. Titration of dietary iodine for maintaining serum thyroxine concentrations in hyperthyroid cats [abstract]. J Vet Intern Med 26:683.

463 Melendez, L.M., R.M. Yamka, and S.D. Forrester. 2011b. Titration of dietary iodine for reducing serum thyroxine concentrations in newly diagnosed hyperthyroid cats (abstract). J Vet Intern Med 25:683.

464 Mellanby, R.J., R.K. Stevenson, M.E. Herrtage, et al. 2002. Long‐term outcome of 56 dogs with nasal tumours treated with four doses of radiation at intervals of seven days. Vet Rec 151:253–257.

465 Michels, G.M., D.W. Knapp, D.B. Denicola, et al. 2002. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor‐free versus nontumor‐free margins: A retrospective study of 31 cases. J Am Anim Hosp Assoc 38:458–466.

466 Miller, M.A., J.A. Ramos, and J.M. Kreeger. 1992. Cutaneous vascular neoplasia in 15 cats: Clinical, morphologic, and immunohistochemical studies. Vet Pathol 29:329–336.

467 Miller, R.L., S. Van Lelyveld, J. Warland, et al. 2016. A retrospective review of treatment and response of high‐risk mast cell tumours in dogs. Vet Comp Oncol 14(4):361–370.

468 Milner, R.J., C.D. Channell, J.K. Levy, et al. 2006. Survival times for cats with hyperthyroidism treated with iodine 131, methimazole, or both: 167 cases (1996–2003). J Am Vet Med Assoc 228:559–563.

469 Milner, R.J., I. Dormehl, W.K. Louw, et al. 1998. Targeted radiotherapy with Sm‐153‐EDTMP in nine cases of canine primary bone tumors. J S Afr Vet Assoc 69:12–17.

470 Milovancev, M., D.M. Wilson, E. Monnet, et al. 2014. Partial resection of the hyoid apparatus during surgical treatment of ectopic thyroid carcinomas in dogs: 5 cases (2011–2013). J Am Vet Med Assoc 244:1319–1324.

471 Moldovanu, G., M. Friedman, and D.G. Miller. 1966. Treatment of canine malignant lymphoma with surgery and chemotherapy. J Am Vet Med Assoc 148:153–156.

472 Molnar, T. and P. Vajdovich. 2012. Clinical factors determining the efficacy of urinary bladder tumour treatments in dogs: Surgery, chemotherapy or both? Acta Vet Hung 60:55–68.

473 Monteiro, B., S. Boston, and G. Monteith. 2011. Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: A retrospective study in 100 dogs. Can Vet J 52:1209–1214.

474 Montgomery, R.D. and G.H. Hankes. 1987. Ureterocolonic anastomosis in a dog with transitional cell carcinoma of the urinary bladder. J Am Vet Med Assoc 190:1427–1429.

475 Montinaro, V., S.E. Boston, P. Buracco, et al. 2013. Clinical outcome of 42 dogs with scapular tumors treated by scapulectomy: A Veterinary Society of Surgical Oncology (VSSO) retrospective study (1995–2010). Vet Surg 42:943–950.

476 Mooney, C.T. 2001. Feline hyperthyroidism. Diagnostics and therapeutics. Vet Clin North Am Small Anim Pract 31:963–983, viii.

477 Moore, A.S. 1993. Recent advances in chemotherapy for nonlymphoid malignant neoplasms. Compend Contin Educ Pract Vet 15:1039–1050.

478 Moore, A.S., S.M. Cotter, W.M. Rand, et al. 2001. Evaluation of a discontinuous treatment protocol (Velcap‐S) for canine lymphoma. J Vet Intern Med 15:348–354.

479 Moore, A.S., C. Kirk, and A. Cardona. 1991a. Intracavitary cisplatin chemotherapy experience with six dogs. J Vet Intern Med 5:227–231.

480 Moore, A.S., C. Kirk, and A. Cardona. 1991b. Intracavitary cisplatin chemotherapy experience with six dogs. J Vet Intern Med 5:277–231.

481 Moore, A.S., R.W. Nelson, C.J. Henry, et al. 2002. Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989–1999). J Am Vet Med Assoc 221:811–818.

482 Moore, A.S., G.H. Theilen, A.D. Newell, et al. 1991c. Preclinical study of sequential tumor necrosis factor and interleukin 2 in the treatment of spontaneous canine neoplasms. Cancer Res 51:233–238.

483 Morello, E., P. Buracco, M. Martano, et al. 2001. Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs. J Small Anim Pract 42:61–66.

484 Morello, E., M. Martano, C. Squassino, et al. 2008. Transanal pull‐through rectal amputation for treatment of colorectal carcinoma in 11 dogs. Vet Surg 37:420–426.

485 Morello, E., E. Vasconi, M. Martano, et al. 2003. Pasteurized tumoral autograft and adjuvant chemotherapy for the treatment of canine distal radial osteosarcoma: 13 cases. Vet Surg 32:539–544.

486 Morris, J.S., J.M. Dobson, D.E. Bostock, et al. 1998. Effect of ovariohysterectomy in bitches with mammary neoplasms. Vet Rec 142:656–658.

487 Morrison‐Collister, K.E., K.M. Rassnick, N.C. Northrup, et al. 2003. A combination chemotherapy protocol with MOPP and CCNU consolidation (Tufts VELCAP‐SC) for the treatment of canine lymphoma. Vet Comp Oncol 1:180–190.

488 Mueller, F., V. Poirier, K. Melzer, et al. 2005. Palliative radiotherapy with electrons of appendicular osteosarcoma in 54 dogs. in vivo 19:713–716.

489 Mullin, C.M., M.A. Arkans, C.D. Sammarco, et al. 2016. Doxorubicin chemotherapy for presumptive cardiac hemangiosarcoma in dogs(dagger). Vet Comp Oncol 14:e171–e183.

490 Mullins, M.N., W.S. Dernell, S.J. Withrow, et al. 2006. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998–2004). J Am Vet Med Assoc 228:91–95.

491 Muraro, L., F. Aprea, and R.A. White. 2013. Successful management of an arytenoid chondrosarcoma in a dog. J Small Anim Pract 54:33–35.

492 Murphy, S., A. Gutierrez, J. Lawrence, et al. 2008. Laparoscopically implanted tissue expander radiotherapy in canine transitional cell carcinoma. Vet Radiol Ultrasound 49:400–405.

493 Murphy, S., A.M. Hayes, L. Blackwood, et al. 2005. Oral malignant melanoma ‐ the effect of coarse fractionation radiotherapy alone or with adjuvant carboplatin therapy. Vet Comp Oncol 3:222–229.

494 Murphy, S., A.H. Sparkes, A.S. Blunden, et al. 2006. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours. Vet Rec 158:287–291.

495 Murphy, S., A.H. Sparkes, K.C. Smith, et al. 2004. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Vet Rec 154:743–746.

496 Mutsaers, A.J. 2009. Metronomic chemotherapy. Top Companion Anim Med 24:137–143.

497 Mutsaers, A.J., N.W. Glickman, D.B. Denicola, et al. 2002. Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs. J Am Vet Med Assoc 220:1813–1817.

498 Myers, N.C., 3rd, A.S. Moore, W.M. Rand, et al. 1997. Evaluation of a multidrug chemotherapy protocol (Acopa II) in dogs with lymphoma. J Vet Intern Med 11:333–339.

499 Naan, E.C., J. Kirpensteijn, H.S. Kooistra, et al. 2006. Results of thyroidectomy in 101 cats with hyperthyroidism. Vet Surg 35:287–293.

500 Nadeau, M.E. and B.E. Kitchell. 2011. Evaluation of the use of chemotherapy and other prognostic variables for surgically excised canine thyroid carcinoma with and without metastasis. Can Vet J 52:994–998.

501 Nadeau, M.E., B.E. Kitchell, R.L. Rooks, et al. 2004. Cobalt radiation with or without low‐dose cisplatin for treatment of canine naso‐sinus carcinomas. Vet Radiol Ultrasound 45:362–367.

502 Newcombe, J. and M. Chir. 1966. Effect of intra‐arterial nitrogen mustard infusion on wound healing in rabbits: formation of granulation tissue and wound contraction. Ann Surg 163(3):319–329.

503 Nieset, J.R., J.F. Harmon, T.E. Johnson, et al. 2014. Comparison of adaptive radiotherapy techniques for external radiation therapy of canine bladder cancer. Vet Radiol Ultrasound 55:644–650.

504 Nishioko, Y., S. Kyotani, M. Okamura, et al. 1992. A study of embolizing materials for chemo‐embolisation therapy of hepatocellular carcinoma: Embolic effect of cisplatin albumin microspheres using chitin and chitosan in dogs, and changes of cisplatin content in blood and tissue. Chem Pharm Bull (Tokyo) 40:267–268.

505 Nolan, M.W., L. Kogan, L.R. Griffin, et al. 2012. Intensity‐modulated and image‐guided radiation therapy for treatment of genitourinary carcinomas in dogs. J Vet Intern Med 26:987–995.

506 Norris, A.M., E.J. Laing, V.E.O. Valli, et al. 1992. Canine bladder and urethral tumors: A retrospective study of 115 cases (1980–1985). J Vet Intern Med 6:145–153.

507 Northrup, N.C., S.M. Etue, D.M. Ruslander, et al. 2001. Retrospective study of orthovoltage radiation therapy for nasal tumors in 42 dogs. J Vet Intern Med 15:183–189.

508 Northrup, N.C., T.L. Gieger, C.E. Kosarek, et al. 2009. Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs. Vet Comp Oncol 7:38–44.

509 Northrup, N.C., K.M. Rassnick, T.L. Gieger, et al. 2013. Prospective evaluation of biweekly streptozotocin in 19 dogs with insulinoma. J Vet Intern Med 27:483–490.

510 Novosad, C.A., P.J. Bergman, M.G. O’Brien, et al. 2006. Retrospective evaluation of adjunctive doxorubicin for the treatment of feline mammary gland adenocarcinoma: 67 cases. J Am Anim Hosp Assoc 42:110–120.

511 Nucci, D.J., J.M. Liptak, L.E. Selmic, et al. 2014. Complications and outcomes following rectal pull‐through surgery in dogs with rectal masses: 74 cases (2000–2013). J Am Vet Med Assoc 245:684–695.

512 O’Brien, M.G., S.J. Withrow, and R.C. Straw. 1996. Limb‐sparing surgery versus amputation for dogs with bone tumors. Vet Clin North Am Small Anim Pract 26:135–143.

513 Oblak, M.L., S.E. Boston, G. Higginson, et al. 2012. The impact of pamidronate and chemotherapy on survival times in dogs with appendicular primary bone tumors treated with palliative radiation therapy. Vet Surg 41:430–435.

514 O’Connell, K. and M. Thomson. 2013. Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases. Vet Comp Oncol 11:51–62.

515 O’Connor, C.M., S. Sheppard, C.A. Hartline, et al. 2012. Adoptive T‐cell therapy improves treatment of canine non‐Hodgkin lymphoma post chemotherapy. Sci Rep 2:249.

516 O’Connor, C.M. and H. Wilson‐Robles. 2014. Developing T cell cancer immunotherapy in the dog with lymphoma. ILAR J 55:169–181.

517 Ogilvie, G.K., J.E. Obradovich, R.E. Elmslie, et al. 1991. Efficacy of mitoxantrone against various neoplasms in dogs. J Am Vet Med Assoc 198:1618–1621.

518 Ogilvie, G.K., B.E. Powers, C.H. Mallinckrodt, et al. 1996. Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 10:379–384.

519 Olsen, J., J. Komtebedde, A. Lackner, et al. 1994. Cytoreductive treatment of ovarian carcinoma in a dog. J Vet Intern Med 8:133–135.

520 Osborne, C.A., V. Perman, J.H. Sautter, et al. 1968. Multiple myeloma in the dog. J Am Vet Med Assoc 153:1300–1319.

521 O’Sullivan, B., A.M. Davis, R. Turcotte, et al. 2002. Preoperative versus postoperative radiotherapy in soft‐tissue sarcoma of the limbs: A randomised trial. Lancet 359:2235–2241.

522 O’Sullivan, B., P. Gullane, J. Irish, et al. 2003. Preoperative radiotherapy for adult head and neck soft tissue sarcoma: Assessment of wound complication rates and cancer outcome in a prospective series. World J Surg 27:875–883.

523 Ottnod, J.M., R.C. Smedley, R. Walshaw, et al. 2013. A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma. Vet Comp Oncol 11:219–229.

524 Overly, B., M. Goldschmidt, F. Schofer, et al. 2001. Canine oral melanoma: A retrospective study. Vet Cancer Soc Proc 21:43.

525 Pack, L., R.E. Roberts, S.D. Dawson, et al. 2001. Definitive radiation therapy for infiltrative thyroid carcinoma in dogs. Vet Radiol Ultrasound 42:471–474.

526 Padgett, S. 2002. Feline thyroid surgery. Vet Clin North Am Small Anim Pract 32:851–859, vi.

527 Page, R.L., D.W. Macy, G.K. Ogilvie, et al. 1992. Phase Iii evaluation of doxorubicin and whole‐body hyperthermia in dogs with lymphoma. Int J Hyperthermia 8:187–197.

528 Page, R.L., D.E. Thrall, M.W. Dewhirst, et al. 1991. Phase I study of melphalan alone and melphalan plus whole body hyperthermia in dogs with malignant melanoma. Int J Hyperthermia 7:559–566.

529 Panciera, D.L., O.I. Lanz, and D.M. Vail. 2004. Treating thyroid and parathyroid neoplasia in dogs and cats. Vet Med 99:154.

530 Paoloni, M.C., D.G. Penninck, and A.S. Moore. 2002. Ultrasonographic and clinicopathologic findings in 21 dogs with intestinal adenocarcinoma. Vet Radiol Ultrasound 43:562–567.

531 Patnaik, A.K., W.J. Ehler, and E.G. MacEwen. 1984. Canine cutaneous mast cell tumor: Morphologic grading and survival time in 83 dogs. Vet Pathol 21:469–474.

532 Patnaik, A.K., S.K. Liu, and G.F. Johnson. 1976. Feline intestinal adenocarcinoma. A clinicopathologic study of 22 cases. Vet Pathol 13:1–10.

533 Pavlin, D., C. Cemazar, A. Cor, et al. 2011. Electrogene therapy with interleukin‐12 in canine mast cell tumors. Radiol Oncol 45:31–39.

534 Pena, F.J., J.A. Gines, J. Duque, et al. 2006. Endometrial adenocarcinoma and mucometra in a 6‐year‐old Alaska Malamute dog. Reprod Domest Anim 41:189–190.

535 Petersen, M.E. and D.V. Becker. 1995. Radioiodine treatment of 524 cats with hyperthyroidism. J Am Vet Med Assoc 207:1422–1428.

536 Peterson, M.E., P.P. Kintzer, J.R. Hurley, et al. 1989. Radioactive iodine treatment of a functional thyroid carcinoma producing hyperthyroidism in a dog. J Vet Intern Med 3:20–25.

537 Peterson, M.E., P.P. Kintzer, and A.I. Hurvitz. 1988. Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med 2:150–157.

538 Phelps, H.A., C.A. Kuntz, R.J. Milner, et al. 2011. Radical excision with five‐centimeter margins for treatment of feline injection‐site sarcomas: 91 cases (1998–2002). J Am Vet Med Assoc 239:97–106.

539 Phillips, B., B.E. Powers, W.S. Dernell, et al. M. 2009. Use of single‐agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. J Am Anim Hosp Assoc 45:33–38.

540 Pirkey‐Ehrhart, N., S.J. Withrow, R.C. Straw, et al. 1995. Primary rib tumors in 54 dogs. J Am Anim Hosp Assoc 31:65–69.

541 Pisarev, M.A., M.A. Dagrosa, L. Thomasz, et al. 2006. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma]. Medicina (B Aires) 66:569–573.

542 Poirier, V.J., W.M. Adams, L.J. Forrest, et al. 2006. Radiation therapy for incompletely excised grade II canine mast cell tumors. J Am Anim Hosp Assoc 42:430–434.

543 Poirier, V.J., K.E. Burgess, W.M. Adams, et al. 2004a. Toxicity, dosage, and efficacy of vinorelbine (Navelbine) in dogs with spontaneous neoplasia. J Vet Intern Med 18:536–539.

544 Poirier, V.J., L.J. Forrest, W.M. Adams, et al. 2004b. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: A pilot study. J Am Anim Hosp Assoc 40:131–136.

545 Poirier, V.J., D.H. Thamm, I.D. Kurzman, et al. 2002. Liposome‐encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine‐associated sarcoma in cats. J Vet Intern Med 16:726–731.

546 Polton, G.A. and M.J. Brearley. 2007. Clinical stage, therapy, and prognosis in canine anal sac gland carcinoma. J Vet Intern Med 21:274–280.

547 Polton, G.A., M.J. Brearley, S.M. Powell, et al. 2008. Impact of primary tumour stage on survival in dogs with solitary lung tumours. J Small Anim Pract 49:66–71.

548 Polton, G.A., R.N. White, M.J. Brearley, et al. 2007. Improved survival in a retrospective cohort of 28 dogs with insulinoma. J Small Anim Pract 48:151–156.

549 Pooya, H.A., B. Seguin, D.R. Mason, et al. 2004. Biomechanical comparison of cortical radial graft versus ulnar transposition graft limb‐sparing techniques for the distal radial site in dogs. Vet Surg 33:301–308.

550 Popovitch, C.A., M.J. Weinstein, and M.H. Goldschmidt. 1994. Chondrosarcoma: A retrospective study of 97 dogs (1987–1990). J Am Anim Hosp Assoc 30:81–85.

551 Porcellato, I., L. Menchetti, C. Brachelente, et al. 2017. Feline injection‐site sarcoma. Vet Pathol 54:204–211.

552 Post, G.S. and G.N. Mauldin. 1992. Radiation and adjuvant chemotherapy for the treatment of thyroid adenocarcinoma in dogs. In Proceedings Veterinary Cancer Society, 12th Annual Conference, Pacific Grove, CA, Oct 18–21, pp. 43–44 (abstr).

553 Postorino, N.C., R.J. Berg, B.E. Powers, et al. 1988. Prognostic variables for canine haemangiopericytoma: 50 cases (1979–1984). J Am Anim Hosp Assoc 24:501–509.

554 Postorino, N.C., S.J. Susaneck, S. J. Withrow, et al. 1989. Single agent therapy with Adriamycin for canine lymphosarcoma. J Am Anim Hosp Assoc 25:221–225.

555 Potanas, C.P., S. Padgett, and R.M. Gamblin. 2015. Surgical excision of anal sac apocrine gland adenocarcinomas with and without adjunctive chemotherapy in dogs: 42 cases (2005–2011). J Am Vet Med Assoc 246:877–884.

556 Pratschke, K.M., M.J. Atherton, J.A. Sillito, et al. 2013. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008–2012). J Am Vet Med Assoc 243:1436–1441.

557 Proulx, D.R., D.M. Ruslander, R.K. Dodge, et al. 2003. A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation. Vet Radiol Ultrasound 44:352–359.

558 Prpich, C.Y., A.C. Santamaria, J.O. Simcock, et al. 2014. Second intention healing after wide local excision of soft tissue sarcomas in the distal aspects of the limbs in dogs: 31 cases (2005–2012). J Am Vet Med Assoc 244:187–194.

559 Prymak, C., L.J. McKee, M.H. Goldschmidt, et al. 1988. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J Am Vet Med Assoc 193:706–712.

560 Quintin‐Colonna, F., P. Devauchelle, D. Fradelizi, et al. 1996. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin‐2. Gene Ther 3:1104–1112.

561 Ramirez, O., III, R.K. Dodge, R.L. Page, et al. 1999. Palliative radiotherapy of appendicular osteosarcoma in 95 dogs. Vet Radiol Ultrasound 40:517–522.

562 Ramirez, G.A., J. Altimira, and M. Vilafranca. 2015. Cartilaginous tumors of the larynx and trachea in the dog: Literature review and 10 additional cases (1995–2014). Vet Pathol 52:1019–1026.

563 Ramos‐Vara, J.A., M.E. Beissenherz, M.A. Miller, et al. 2000. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Vet Pathol 37:597–608.

564 Rassnick, K.M., D.B. Bailey, E.K. Malone, et al. 2014. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma. J Am Anim Hosp Assoc 50:167–173.

565 Rassnick, K.M., C.E. Goldkamp, H.N. Erb, et al. 2006. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993–2003). J Am Vet Med Assoc 229:401–406.

566 Rassnick, K.M., G.E. Mauldin, R. Al‐Sarraf, et al. 2002. Mopp chemotherapy for treatment of resistant lymphoma in dogs: A retrospective study of 117 cases (1989–2000). J Vet Intern Med 16:576–580.

567 Rassnick, K.M., M.C. McEntee, H.N. Erb, et al. 2007. Comparison of 3 protocols for treatment after induction of remission in dogs with lymphoma. J Vet Intern Med 21:1364–1373.

568 Rassnick, K.M., A.S. Moore, D.S. Russell, et al. 2010. Phase II, open‐label trial of single‐agent CCNU in dogs with previously untreated histiocytic sarcoma. J Vet Intern Med 24:1528–1531.

569 Rassnick, K.M., A.S. Moore, L.E. Williams, et al. 1999. Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 13:601–605.

570 Rassnick, K.M., D.M. Ruslander, S.M. Cotter, et al. 2001. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989–2000). J Am Vet Med Assoc 218:1444–1448.

571 Rebhun, R.B., M.S. Kent, S.A. Borrofka, et al. 2011. Chop chemotherapy for the treatment of canine multicentric T‐cell lymphoma. Vet Comp Oncol 9:38–44.

572 Renwick, A. and E. Scurrell. 2013. Orthogonal bone plate stabilization for limb‐sparing surgery. Vet Comp Orthop Traumatol 26:505–509.

573 Huppes, R.R., L.Z. Crivellenti, A. Barboza De Nardi, et al. 2017. Radical cystectomy and cutaneous ureterostomy in 4 dogs with trigonal transitional cell carcinoma: Description of technique and case series. Vet Surg 46:111–119.

574 Riccardo, F., S. Iussich, L. Maniscalco, et al. 2014. CSPG4‐specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA. Clin Cancer Res 20:3753–3762.

575 Ridgway, T.D. and M.D. Lucroy. 2003. Phototoxic effects of 635‐nm light on canine transitional cell carcinoma cells incubated with 5‐aminolevulinic acid. Am J Vet Res 64:131–136.

576 Robat, C., J. Burton, D. Thamm, et al. 2013a. Retrospective evaluation of doxorubicin‐piroxicam combination for the treatment of transitional cell carcinoma in dogs. J Small Anim Pract 54:67–74.

577 Robat, C.S., L. Cesario, R. Gaeta, et al. 2013b. Clinical features, treatment options, and outcome in dogs with thymoma: 116 cases (1999–2010). J Am Vet Med Assoc 243:1448–1454.

578 Robat, C., C. London, L. Bunting, et al. 2012. Safety evaluation of combination vinblastine and toceranib phosphate (Palladia(R)) in dogs: A phase I dose‐finding study. Vet Comp Oncol 10:174–183.

579 Robben, J.H., W.E. Van Den Brom, J.A. Mol, et al. 2006. Effect of octreotide on plasma concentrations of glucose, insulin, glucagon, growth hormone, and cortisol in healthy dogs and dogs with insulinoma. Res Vet Sci 80:25–32.

580 Rodenas, S., I. Valin, P. Devauchelle, et al. 2006. Combined use of surgery and radiation in the treatment of an intradural myxoid liposarcoma in a dog. J Am Anim Hosp Assoc 42:386–391.

581 Romansik, E.M., C.M. Reilly, P.H. Kass, et al. 2007. Mitotic index is predictive for survival for canine cutaneous mast cell tumors. Vet Pathol 44:335–341.

582 Rosales, C., K.A. Jeglum, M. Obrocka, et al. 1988. Cytolytic activity of murine anti‐dog lymphoma monoclonal antibodies with canine effector cells and complement. Cell Immunol 115:420–428.

583 Ross, J.T., T.D. Scavelli, D.T. Matthieson, et al. 1991. Adenocarcinoma of the apocrine glands of the anal sac in dogs: A review of 32 cases. J Am Anim Hosp Assoc 27:349–355.

584 Rottenberg, S., C. Von Tscharner, and P.J. Roosje. 2004. Thymoma‐associated exfoliative dermatitis in cats. Vet Pathol 41:429–433.

585 Rovesti, G.L., M. Bascucci, K. Schmidt, et al. 2002. Limb sparing using a double bone‐transport technique for treatment of a distal tibial osteosarcoma in a dog. Vet Surg 31:70–77.

586 Rusbridge, C., S.J. Wheeler, C.R. Lamb, et al. 1999. Vertebral plasma cell tumors in 8 dogs. J Vet Intern Med 13:126–133.

587 Saam, D.E., J.M. Liptak, M.J. Stalker, et al. 2011. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996–2006). J Am Vet Med Assoc 238:195–206.

588 Saba, C.F., S.D. Hafeman, D.M. Vail, et al. 2009. Combination chemotherapy with continuous L‐asparaginase, lomustine, and prednisone for relapsed canine lymphoma. J Vet Intern Med 23:1058–1063.

589 Saba, C.F., D.H. Thamm, and D.M. Vail. 2007. Combination chemotherapy with L‐asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma. J Vet Intern Med 21:127–132.

590 Saba, C.F., D.M. Vail, and D.H. Thamm. 2012. Phase II clinical evaluation of lomustine chemotherapy for feline vaccine‐associated sarcoma. Vet Comp Oncol 10:283–291.

591 Saeki, K., A. Fujita, N. Fujita, et al. 2015. Total cystectomy and subsequent urinary diversion to the prepuce or vagina in dogs with transitional cell carcinoma of the trigone area: A report of 10 cases (2005–2011). Can Vet J 56:73–80.

592 Salinardi, B.J., S.L. Marks, J.R. Davidson, et al. 2003. The use of a low‐profile cystostomy tube to relieve urethral obstruction in a dog. J Am Anim Hosp Assoc 39:403–405.

593 Salm, R., B. Wullich, G. Kiefer, et al. 1991. Effects of a three‐drug antineoplastic protocol of wound healing in rats: A biomechanical and histologic study on gastrointestinal anastomoses and laparotomy wounds. J Surg Oncol 47:5–11.

594 Santos, A.A., C.C. Lopes, J.R. Ribeiro, et al. 2013. Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study. BMC Vet Res 9:1.

595 Sartor, L.L., L.A. Trepanier, M.M. Kroll, et al. 2004. Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism. J Vet Intern Med 18:651–655.

596 Sauerbrey, M.L., M.N. Mullins, E.O. Bannink, et al. 2007. Lomustine and prednisone as a first‐line treatment for dogs with multicentric lymphoma: 17 cases (2004–2005). J Am Vet Med Assoc 230:1866–1869.

597 Saulnier‐Troff, F.G., V. Busoni, and A. Hamaide. 2008. A technique for resection of invasive tumors involving the trigone area of the bladder in dogs: Preliminary results in two dogs. Vet Surg 37:427–437.

598 Scase, T.J., D. Edwards, J. Miller, et al. 2006. Canine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosis. J Vet Intern Med 20:151–158.

599 Schrempp, D.R., M.O. Childress, J.C. Stewart, et al. 2013. Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma. J Am Vet Med Assoc 242:1534–1538.

600 Schuller, D.E., B. Metch, D.W. Stein, et al. 1988. Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group. Laryngoscope 98:1205–1211.

601 Schultheiss, P.C. 2004. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Invest 16:522–526.

602 Schwarz, P.D., S.J. Withrow, C.R. Curtis, et al. 1991b. Mandibular resection as a treatment for oral cancer in 81 dogs. J Am Anim Hosp Assoc 27:601–610.

603 Schwarz, P.D., S.J. Withrow, C.R. Curtis, et al. 1991a. Partial maxillary resection as a treatment for oral cancer in 61 dogs. J Am Anim Hosp Assoc 27:617–624.

604 Scott‐Moncrieff, J.C., H.G. Heng, H.Y. Weng, et al. 2015. Effect of a limited iodine diet on iodine uptake by thyroid glands in hyperthyroid cats. J Vet Intern Med 29:1322–1326.

605 Seguin, B., N.F. Leibman, V.S. Bregazzi, et al. 2001. Clinical outcome of dogs with grade‐II mast cell tumors treated with surgery alone: 55 cases (1996–1999). J Am Vet Med Assoc 218:1120–1123.

606 Seguin, B., D.E. McDonald, M.S. Kent, et al. 2005. Tolerance of cutaneous or mucosal flaps placed into a radiation therapy field in dogs. Vet Surg 34:214–222.

607 Seguin, B., M.D. O’Donnell, P.J. Walsh, et al. 2017. Long‐term outcome of dogs treated with ulnar rollover transposition for limb‐sparing of distal radial osteosarcoma: 27 limbs in 26 dogs. Vet Surg 46:1017–1024.

608 Seguin, B., P.J. Walsh, D.R. Mason, et al. 2003. Use of an ipsilateral vascularized ulnar transposition autograft for limb‐sparing surgery of the distal radius in dogs: An anatomic and clinical study. Vet Surg 32:69–79.

609 Seiler, R.J. 1979. Colorectal polyps of the dog: A clinicopathologic study of 17 cases. J Am Vet Med Assoc 174:72–75.

610 Selmic, L.E., J.H. Burton, D.H. Thamm, et al. 2014. Comparison of carboplatin and doxorubicin‐based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med 28:554–563.

611 Selting, K.A., B.E. Powers, L.J. Thompson, et al. 2005. Outcome of dogs with high‐grade soft tissue sarcomas treated with and without adjuvant doxorubicin chemotherapy: 39 cases (1996–2004). J Am Vet Med Assoc 227:1442–1448.

612 Seo, K.W., U.S. Choi, Y.C. Jung, et al. 2007. Palliative intravenous cisplatin treatment for concurrent peritoneal and pleural mesothelioma in a dog. J Vet Med Sci 69:201–204.

613 Shirafuji, T., T. Oka, T. Sawada, et al. 2001. The importance of peripheral blood leukocytes and macrophage infiltration on bronchial wall wound healing in rats treated preoperatively with anticancer agents. Surg Today 31:308–316.

614 Shiu, K.B., A.B. Flory, C.L. Anderson, et al. 2011. Predictors of outcome in dogs with subcutaneous or intramuscular hemangiosarcoma. J Am Vet Med Assoc 238:472–479.

615 Sicotte, V., J. Benamou, L.C. Fifle, et al. 2012. Use of surgery and mitoxantrone chemotherapy in a dog with disseminated lymphangiosarcoma. J Am Vet Med Assoc 241:1639–1644.

616 Silver, M., A. Rusk, B. Phillips, et al. 2012. Evaluation of the oral antimitotic agent (Abt‐751) in dogs with lymphoma. J Vet Intern Med 26:349–354.

617 Simcock, J.O., S.S. Withers, C.Y. Prpich, et al. 2012. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006–2010). J Am Vet Med Assoc 241:608–614.

618 Simpson, A.M., L.L. Ludwig, S.J. Newman, et al. 2004. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 224:236–240.

619 Singh, A., S.E. Boston, and R. Poma. 2010. Thymoma‐associated exfoliative dermatitis with post‐thymectomy myasthenia gravis in a cat. Can Vet J 51:757–760.

620 Sivacolundhu, R.K., J.J. Runge, T.A. Donovan, et al. 2013. Ulnar osteosarcoma in dogs: 30 cases (1992–2008). J Am Vet Med Assoc 243:96–101.

621 Skorupski, K.A., C.A. Clifford, M.C. Paoloni, et al. 2007. CCNU for the treatment of dogs with histiocytic sarcoma. J Vet Intern Med 21:121–126.

622 Skorupski, K.A., C.O. Rodriguez, E.L. Krick, et al. 2009. Long‐term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy. Vet Comp Oncol 7:139–144.

623 Skorupski, K.A., J.M. Uhl, A. Szivek, et al. 2016. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: A randomized, phase III trial. Vet Comp Oncol 14(1):81–87.

624 Slawienski, M.J., G.E. Mauldin, G.N. Mauldin, et al. 1997. Malignant colonic neoplasia in cats: 46 cases (1990–1996). J Am Vet Med Assoc 211:878–881.

625 Sleeckx, N., H. De Rooster, E.J. Veldhuis Kroeze, et al. 2011. Canine mammary tumours, an overview. Reprod Domest Anim 46:1112–1131.

626 Smith, J., M. Kiupel, J. Farrelly, et al. 2017. Recurrence rates and clinical outcome for dogs with grade II mast cell tumours with a low AgNOR count and Ki67 index treated with surgery alone. Vet Comp Oncol 15:36–45.

627 Smith, J.D., E.A. Stone, and S.D. Gilson. 1995. Placement of a permanent cystostomy catheter to relieve urine outflow obstruction in dogs with transitional cell carcinoma. J Am Vet Med Assoc 206:496–499.

628 Smith, A.N., J.C. Wright, W.R. BrawnerJr., et al. 2001. Radiation therapy in the treatment of canine and feline thymomas: A retrospective study (1985–1999). J Am Anim Hosp Assoc 37:489–496.

629 Song, T., W. Wang, P. Liu, et al. 2009. Pharmacokinetic comparison between pelvic transarterial chemoembolization and transcatheter arterial chemotherapy in an animal model. Mol Med Rep 2:663–667.

630 Sorenmo, K.U., J.L. Baez, C.A. Clifford, et al. 2004a. Efficacy and toxicity of a dose‐intensified doxorubicin protocol in canine hemangiosarcoma. J Vet Intern Med 18:209–213.

631 Sorenmo, K., L. Duda, L. Barber, et al. 2000a. Canine hemangiosarcoma treated with standard chemotherapy and minocycline. J Vet Intern Med 14:395–398.

632 Sorenmo, K.U., M.H. Goldschmidt, F.S. Shofer, et al. 2004b. Evaluation of cyclooxygenase‐1 and cyclooxygenase‐2 expression and the effect of cyclooxygenase inhibitors in canine prostatic carcinoma. Vet Comp Oncol 2:13–23.

633 Sorenmo, K.U., K.A. Jeglum, and S.C. Helfand. 1993. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. J Vet Intern Med 7:370–376.

634 Sorenmo, K.U., E. Krick, C.M. Coughlin, et al. 2011. CD40‐activated B cell cancer vaccine improves second clinical remission and survival in privately owned dogs with non‐Hodgkin's lymphoma. PLoS One 6:e24167.

635 Sorenmo, K., B. Overley, E. Krick, et al. 2010. Outcome and toxicity associated with a dose‐intensified, maintenance‐free CHOP‐based chemotherapy protocol in canine lymphoma: 130 cases. Vet Comp Oncol 8:196–208.

636 Sorenmo, K.U., M. Samluk, C.A. Clifford, et al. 2005. Efficacy and toxicity of intracavitary administration of pegylated liposomal encapsulated doxorubicin (Doxil) in dogs with haemangiosarcoma. Vet Comp Oncol 3(1):55–56.

637 Sorenmo, K.U., F.S. Shofer, and M.H. Goldschmidt. 2000b. Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J Vet Intern Med 14:266–270.

638 Sorenmo, K.U., D.R. Worley, and M.H. Goldschmidt. 2013. 27 – Tumors of the mammary gland. In Withrow and MacEwen's Small Animal Clinical Oncology, 5th edition. R.L. Page, S.J. Withrow, and D.M. Vail, editors. St. Louis: W.B. Saunders.

639 Spangler, W.L. and M.R. Culbertson. 1992. Prevalence, type, and importance of splenic diseases in dogs: 1,480 cases (1985–1989). J Am Vet Med Assoc 200:829–834.

640 Spangler, W.L. and P.H. Kass. 1997. Pathologic factors affecting postsplenectomy survival in dogs. J Vet Intern Med 11:166–171.

641 Sparkes, A., S. Murphy, F. McConnell, et al. 2005. Palliative intracavitary carboplatin therapy in a cat with suspected pleural mesothelioma. J Feline Med Surg 7:313–316.

642 Spodnick, G.J., J. Berg, W.M. Rand, et al. 1992. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978–1988). J Am Vet Med Assoc 200:995–999.

643 Spugnini, E.P. 2002. Use of hyaluronidase for the treatment of extravasation of chemotherapeutic agents in six dogs. J Am Vet Med Assoc 221:1437–1440, 1419–1420.

644 Spugnini, E.P., T. Azzarito, and S. Fais. 2016. Electrochemotherapy as first line cancer treatment: Experiences from veterinary medicine in developing novel protocols. Curr Drug Targets 16:43–52.

645 Spugnini, E.P. and A. Baldi. 2019. Electrochemotherapy in veterinary oncology: State if the art and perspectives. Vet Clin North Am 49:967–979.

646 Spugnini, E.P., A. Baldi, and B. Vincenzi. 2007. Intraoperative versus postoperative electrochemotherapy in high‐grade soft tissue sarcomas: A preliminary study in a spontaneous feline model. Cancer Chemother Pharmacol 59:375–381.

647 Spugnini, E.P., S. Crispi, A. Scarabello, et al. 2008. Piroxicam and intracavitary platinum‐based chemotherapy for the treatment of advanced mesothelioma in pets: Preliminary observations. J Exp Clin Cancer Res 27:6.

648 Spugnini, E.P., E. Dragonetti, B. Vincenzi, et al. 2006a. Pulse‐mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma. Melanoma Res 16:23–27.

649 Spugnini, E.P., S. Fais, T. Azzarito, et al. 2017. Novel instruments for the implementation of electrochemotherapy protocols: From bench side to veterinary clinic. J Cell Physiol 232:490–495.

650 Spugnini, E.P., B. Vincenzi, B. Amadio, et al. 2019. Adjuvant electrochemotherapy with bleomycin and cisplatin combination for canine soft tissue sarcomas: A study of 30 cases. Open Vet J 9:88–93.

651 Spugnini, E.P., B. Vincenzi, F. Baldi, et al. 2006b. Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors. Anticancer Res 26:4585–4590.

652 Spugnini, E.P., B. Vincenzi, G. Caruso, et al. 2009. Zoledronic acid for the treatment of appendicular osteosarcoma in a dog. J Small Anim Pract 50:44–46.

653 Stanclift, R.M. and S.D. Gilson. 2004. Use of cisplatin, 5‐fluorouracil, and second‐look laparotomy for the management of gastrointestinal adenocarcinoma in three dogs. J Am Vet Med Assoc 225:1412–1417, 1393.

654 Stanclift, R.M. and S.D. Gilson. 2008. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs. J Am Vet Med Assoc 232:53–62.

655 Stefanello, D., G. Avallone, R. Ferrari, et al. 2011. Canine cutaneous perivascular wall tumors at first presentation: Clinical behavior and prognostic factors in 55 cases. J Vet Intern Med 25:1398–1405.

656 Stefanello, D., P. Buracco, S. Sabattini, et al. 2015. Comparison of 2‐ and 3‐category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009–2014). J Am Vet Med Assoc 246:765–769.

657 Stepien, R.L., N.T. Whitley, and R.R. Dubielzig. 2000. Idiopathic or mesothelioma‐related pericardial effusion: Clinical findings and survival in 17 dogs studied retrospectively. J Small Anim Pract 41:342–347.

658 Steplewski, Z., C. Rosales, K.A. Jeglum, et al. 1990. in vivo destruction of canine lymphoma mediated by murine monoclonal antibodies. in vivo 4:231–234.

659 Stone, E.A., T.F. George, S.D. Gilson, et al. 1996. Partial cystectomy for urinary bladder neoplasia: Surgical technique and outcome in 11 dogs. J Small Anim Pract 37:480–485.

660 Stone, M.S., M.A. Goldstein, and S.M. Cotter. 1991. Comparison of two protocols for induction of remission in dogs with lymphoma. J Am Anim Hosp Assoc 27:315–321.

661 Stone, E.A., S.J. Withrow, R.L. Page, et al. 1988. Ureterocolonic anastomosis in ten dogs with transitional cell carcinoma. Vet Surg 17:147–153.

662 Straw, R.C., R.A. Lecouteur, B.E. Powers, et al. 1989. Multilobular osteochondrosarcoma of the canine skull: 16 cases (1978–1988). J Am Vet Med Assoc 195:1764–1769.

663 Straw, R.C., S.J. Withrow, E.B. Douple, et al. 1994. The effects of cisdiamminedichloroplatinum II released from D,L,‐polylactic acid implanted adjacent to cortical allografts in dogs. J Orthop Res 12:871–877.

664 Straw, R.C., S.J. Withrow, and B.E. Powers. 1991a. Primary Osteosarcoma of the ulna in 12 dogs. J Am Anim Hosp Assoc 27:323–326.

665 Straw, R.C., S.J. Withrow, and B.E. Powers. 1992. Partial or total hemipelvectomy in the management of sarcomas in nine dogs and two cats. Vet Surg 21:183–188.

666 Straw, R.C., S.J. Withrow, S.L. Richter, et al. 1991b. Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med 5:205–210.

667 Sun, F., J. Hernandez, J. Ezquerra, et al. 2002. Angiographic study and therapeutic embolization of soft‐tissue fibrosarcoma in a dog: Case report and literature. J Am Anim Hosp Assoc 38:452–457.

668 Swann, H.M. and D.E. Holt. 2002. Canine gastric adenocarcinoma and leiomyosarcoma: A retrospective study of 21 cases (1986–1999) and literature review. J Am Anim Hosp Assoc 38:157–164.

669 Swiderski, J. and S. Withrow. 2009. A novel surgical stapling technique for rectal mass removal: A retrospective analysis. J Am Anim Hosp Assoc 45:67–71.

670 Szivek, A., R.E. Burns, B. Gericota, et al. 2012. Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993–2007. Vet Comp Oncol 10:65–73.

671 Taeymans, O., D.G. Penninck, and R.M. Peters. 2013. Comparison between clinical, ultrasound, CT, MRI, and pathology findings in dogs presented for suspected thyroid carcinoma. Vet Radiol Ultrasound 54:61–70.

672 Takahashi, M., H. Tomiyasu, E. Hotta, et al. 2014. Clinical characteristics and prognostic factors in dogs with histiocytic sarcomas in Japan. J Vet Med Sci 76:661–666.

673 Tan‐Coleman, B., J. Lyons, C. Lewis, et al. 2013. Prospective evaluation of a 5 x 4 Gy prescription for palliation of canine nasal tumors. Vet Radiol Ultrasound 54:89–92.

674 Tater, G., N. Eberle, S. Hungerbuehler, et al. 2012. Ventricular fractional shortening in 108 dogs with malignant lymphoma undergoing chemotherapy with a cyclic combination protocol including doxorubicin. Tierarztl Prax Ausg K Kleintiere Heimtiere 40:261–266.

675 Taylor, F., R. Gear, T. Hoather, et al. 2009. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. J Small Anim Pract 50:284–289.

676 Taylor, C.W. and S. Kumar. 2005. The effect of immediate breast reconstruction on adjuvant chemotherapy. Breast 14:18–21.

677 Tellado, M.N., F.H. Maglietti, S.D. Michinski, et al. 2020. Electrochemotherapy in treatment of canine oral malignant melanoma and factors influencing treatment outcome. Radiol Oncol 54:68–78.

678 Tepper, L.C., I.B. Spiegel, and G.J. Davis. 2011. Diagnosis of erythema multiforme associated with thymoma in a dog and treated with thymectomy. J Am Anim Hosp Assoc 47:e19–e25.

679 Thamm, D.H., E.A. Mauldin, and D.M. Vail. 1999. Prednisone and vinblastine chemotherapy for canine mast cell tumor‐‐41 cases (1992–1997). J Vet Intern Med 13:491–497.

680 Thamm, D.H., M.M. Turek, and D.M. Vail. 2006. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high‐risk canine mast cell tumour: 61 cases. J Vet Med Sci 68:581–587.

681 Theon, A.P., P.Y. Barthez, B.R. Madewell, et al. 1994. Radiation therapy of ceruminous gland carcinomas in dogs and cats. J Am Vet Med Assoc 205:566–569.

682 Theon, A.P., B.R. Madewell, M.F. Harb, et al. 1993. Megavoltage irradiation of neoplasms of the nasal and paranasal cavities in 77 dogs. J Am Vet Med Assoc 202:1469–1475.

683 Theon, A.P., B.R. Madewell, A.S. Moore, et al. 1991. Localized thermo‐cisplatin therapy: A pilot study in spontaneous canine and feline tumours. Int J Hyperthermia 7:881–892.

684 Theon, A.P., S.L. Marks, E.S. Feldman, et al. 2000. Prognostic factors and patterns of treatment failure in dogs with unresectable differentiated thyroid carcinomas treated with megavoltage irradiation. J Am Vet Med Assoc 216:1775–1779.

685 Theon, A.P., C. Rodriguez, and B.R. Madewell. 1997. Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation. J Am Vet Med Assoc 210:778–784.

686 Thompson, J.P., N. Ackerman, J.R. Bellah, et al. 1992. 192iridium brachytherapy, using an intracavitary afterload device, for treatment of intranasal neoplasms in dogs. Am J Vet Res 53:617–622.

687 Thompson, J.P. and M.J. Fugent. 1992. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979–1990). J Am Vet Med Assoc 200:531–533.

688 Thompson, J.J., D.L. Pearl, J.A. Yager, et al. 2011a. Canine subcutaneous mast cell tumor: Characterization and prognostic indices. Vet Pathol 48:156–168.

689 Thompson, J.J., J.A. Yager, S.J. Best, et al. 2011b. Canine subcutaneous mast cell tumors: Cellular proliferation and Kit expression as prognostic indices. Vet Pathol 48:169–181.

690 Thomson, M.J., S.J. Withrow, W.S. Dernell, et al. 1999. Intermuscular lipomas of the thigh region in dogs: 11 cases. J Am Anim Hosp Assoc 35:165–167.

691 Thrall, D.E. 1981. Orthovoltage radiotherapy of oral fibrosarcomas in dogs. J Am Vet Med Assoc 179:159–162.

692 Thrall, D.E., S.J. Withrow, B.E. Powers, et al. 1990. Radiotherapy prior to cortical allograft limb sparing in dogs with osteosarcoma: A dose response assay. Int J Radiat Oncol Biol Phys 18:1351–1357.

693 Tilmant, L.L., N.T. Gorman, N. Ackerman, et al. 1986. Chemotherapy of synovial cell sarcoma in a dog. J Am Vet Med Assoc 188:530–532.

694 Tobin, R.L., R.W. Nelson, M.D. Lucroy, et al. 1999. Outcome of surgical versus medical treatment of dogs with beta cell neoplasia: 39 cases (1990–1997). J Am Vet Med Assoc 215:226–230.

695 Tomamassini, M., N. Ehrhart, A. Ferretti, et al. 2000. Bone transport osteogenesis for limb salvage following resection of primary bone tumors: Experience with 6 cases (1991–1996). Vet Comp Orthop Trauma 23:43–51.

696 Tomlin, J.L., C. Sturgeon, M.J. Pead, et al. 2000. Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs. Vet Rec 147:129–132.

697 Tran, C.M., A.S. Moore, and A.E. Frimberger. 2016. Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy. Vet Comp Oncol 14(3):252–262.

698 Trepanier, L.A. 2007. Pharmacologic management of feline hyperthyroidism. Vet Clin North Am Small Anim Pract 37:775–788, vii.

699 Trepanier, L.A., S.B. Hoffman, M. Kroll, et al. 2003. Efficacy and safety of once versus twice daily administration of methimazole in cats with hyperthyroidism. J Am Vet Med Assoc 222:954–958.

700 Tripp, C.D., J. Fidel, C.L. Anderson, et al. 2011. Tolerability of metronomic administration of lomustine in dogs with cancer. J Vet Intern Med 25:278–284.

701 Trout, N.J., M.M. Pavletic, and K.H. Kraus. 1995. Partial scapulectomy for management of sarcomas in three dogs and two cats. J Am Vet Med Assoc 207:585–587.

702 Tuohy, J.L., L.E. Selmic, D.R. Worley, et al. 2014. Outcome following curative‐intent surgery for oral melanoma in dogs: 70 cases (1998–2011). J Am Vet Med Assoc 245:1266–1273.

703 Tuohy, J.L., D.R. Worley, and S.J. Withrow. 2012. Outcome following simultaneous bilateral thyroid lobectomy for treatment of thyroid gland carcinoma in dogs: 15 cases (1994–2010). J Am Vet Med Assoc 241:95–103.

704 Turek, M.M., L.J. Forrest, W.M. Adams, et al. 2003. Postoperative radiotherapy and mitoxantrone for anal sac adenocarcinoma in the dog: 15 cases (1991–2001). Vet Comp Oncol 1:94–104.

705 Turrel, J.M. 1987a. Intraoperative radiotherapy of carcinoma of the prostate gland in ten dogs. J Am Vet Med Assoc 190:48–52.

706 Turrel, J.M. 1987b. Principles of radiation therapy. In Veterinary Cancer Medicine. G.H. Thielen and B.R. Madewell, editors. Philadelphia: Lea and Febiger.

707 Turrel, J.M., B.E. Kitchell, L.M. Miller, et al. 1988. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J Am Vet Med Assoc 193:936–940.

708 Turrel, J.M., M.C. McEntee, B.P. Burke, et al. 2006. Sodium iodide I 131 treatment of dogs with nonresectable thyroid tumors: 39 cases (1990–2003). J Am Vet Med Assoc 229:542–548.

709 Upton, M.L., C.H. Tangner, and M.E. Payton. 2006. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma. J Am Vet Med Assoc 228:549–552.

710 U'ren, L.W., B.J. Biller, R.E. Elmslie, et al. 2007. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma. J Vet Intern Med 21:113–120.

711 Vail, D.M. 2007. Plasma cell tumors. In Withrow & MacEwen’s Small Animal Clinical Oncology, 4th edition. S.J. Withrow and D.M. Vail, editors. St. Louis: Saunders.

712 Vail, D.M., A.E. Hershey, and A.S. Moore. 2000. Efficacy of adjuvant inhalational chemotherapy following surgical cytoreduction in dogs with spontaneously arising node positive primary lung cancer. In Proceedings Annual Meeting of American Association for Cancer Research, San Francisco, (abstract 1272). Philadephia: American Association for Cancer Research.

713 Vail, D.M., E.G. MacEwen, I.D. Kurzman, et al. 1995. Liposome‐encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: A randomized multi‐institutional clinical trial. Clin Cancer Res 1:1165–1170.

714 Vail, D.M., B.E. Powers, D.M. Getzy, et al. 1994. Evaluation of prognostic factors for dogs with synovial sarcoma: 36 cases (1986–1991). J Am Vet Med Assoc 205:1300–1307.

715 Vail, D.M., H. Von Euler, A.W. Rusk, et al. 2012. A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs. J Vet Intern Med 26:598–607.

716 Vail, D.M. and K.M. Young. 2007. Canine lymphoma and lymphoid leukaemia. In Withrow & MacEwen’s Small Animal Clinical Oncology, 4th edition. S.J. Withrow and D.M. Vail, editors. St. Louis: Saunders.

717 Valerius, K.D., G.K. Ogilvie, C.H. Mallinckrodt, et al. 1997a. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987–1995). J Am Vet Med Assoc 210:512–516.

718 Valerius, K.D., B.E. Powers, M.A. Mcpherron, et al. 1997b. Adenomatous polyps and carcinoma in situ of the canine colon and rectum: 34 cases (1982–1994). J Am Anim Hosp Assoc 33:156–160.

719 Van Der Kooij, M., I. Becvarova, H.P. Meyer, et al. 2014. Effects of an iodine‐restricted food on client‐owned cats with hyperthyroidism. J Feline Med Surg 16:491–498.

720 Van Ginkel, R.J., H.J. Hoekstra, F.J. Meutstege, et al. 1995. Hyperthermic isolated regional perfusion with cisplatin in the local treatment of spontaneous canine osteosarcoma: Assessment of short‐term effects. J Surg Oncol 59:169–176.

721 Van Lelyveld, S., J. Warland, R. Miller, et al. 2015. Comparison between Ki‐67 index and mitotic index for predicting outcome in canine mast cell tumours. J Small Anim Pract 56:312–319.

722 Vancil, J.M., C.J. Henry, R.J. Milner, et al. 2012. Use of samarium Sm 153 lexidronam for the treatment of dogs with primary tumors of the skull: 20 cases (1986–2006). J Am Vet Med Assoc 240:1310–1315.

723 Vasseur, P. 1987. Limb preservation in dogs with primary bone tumors. Vet Clin North Am Small Anim Pract 17:889–903.

724 Vaudaux, C., U. Schneider, and B. Kaser‐Hotz. 2007. Potential for intensity‐modulated radiation therapy to permit dose escalation for canine nasal cancer. Vet Radiol Ultrasound 48:475–481.

725 Venable, R.O., C.F. Saba, M.M. Endicott, et al. 2012. Dexrazoxane treatment of doxorubicin extravasation injury in four dogs. J Am Vet Med Assoc 240:304–307.

726 Venzin, C., S. Grundmann, and P. Montavon. 2012. Endoprosthesis (EN) in frontlimb‐sparing surgery for distal radial tumours in the dog: Preliminary results. Schweiz Arch Tierheilkd 154:337–343.

727 Villalobos, A. 2006. Dealing with chemotherapy extravasations: A new technique. J Am Anim Hosp Assoc 42:321–325.

728 Vincenti, S. and F. Findji. 2017. Influence of treatment on the outcome of dogs with incompletely excised grade‐2 mast cell tumors. Schweiz Arch Tierheilkd 159:171–177.

729 Von Euler, H., A. Sadeghi, B. Carlsson, et al. 2008. Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma. J Immunother 31:377–384.

730 Walker, M. and M. Breider. 1987. Intraoperative radiotherapy of canine bladder cancer. Vet Radiol 28:200–204.

731 Wallace, J., D.T. Matthiesen, and A.K. Patnaik. 1992. Hemimaxillectomy for the treatment of oral tumors in 69 dogs. Vet Surg 21:337–341.

732 Walter, C.U., W.S. Dernell, S.M. Larue, et al. 2005. Curative‐intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: A preliminary retrospective evaluation of 14 dogs with the disease. Vet Comp Oncol 3:1–7.

733 Waltman, S.S., B. Seguin, B.J. Cooper, et al. 2007. Clinical outcome of nonnasal chondrosarcoma in dogs: Thirty‐one cases (1986–2003). Vet Surg 36:266–271.

734 Wang, Z., W. Qiu, and W.M. Mendenhall. 2003. Influence of radiation therapy on reconstructive flaps after radical resection of head and neck cancer. Int J Oral Maxillofac Surg 32:35–38.

735 Ward, H., L.E. Fox, M.B. Calderwood‐Mays, et al. 1994. Cutaneous hemangiosarcoma in 25 dogs: A retrospective study. J Vet Intern Med 8:345–348.

736 Webster, J.D., V. Yuzbasiyan‐Gurkan, R.A. Miller, et al. 2007. Cellular proliferation in canine cutaneous mast cell tumors: Associations with c‐Kit and its role in prognostication. Vet Pathol 44:298–308.

737 Weisse, C. 2015. Veterinary interventional oncology: From concept to clinic. Vet J 205:198–203.

738 Weisse, C., A. Berent, K. Todd, et al. 2006. Evaluation of palliative stenting for management of malignant urethral obstructions in dogs. J Am Vet Med Assoc 229:226–234.

739 Weisse, C., C.A. Clifford, D. Holt, et al. 2002a. Percutaneous arterial embolization and chemoembolization for treatment of benign and malignant tumors in three dogs and a goat. J Am Vet Med Assoc 221:1430–1436, 1419.

740 Weisse, C., F.S. Shofer, and K. Sorenmo. 2002b. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 38:71–73.

741 Weisse, C., N. Soares, M.W. Beal, et al. 2005. Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy: 23 cases (1986–2000). J Am Vet Med Assoc 226:575–579.

742 Wells, A.L., C.D. Long, W.J. Hornof, et al. 2001. Use of percutaneous ethanol injection for treatment of bilateral hyperplastic thyroid nodules in cats. J Am Vet Med Assoc 218:1293–1297.

743 Wendelburg, K.M., L.L. Price, K.E. Burgess, et al. 2015. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001–2012). J Am Vet Med Assoc 247:393–403.

744 Westberg, S., A. Sadeghi, E. Svensson, et al. 2013. Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma. J Immunother 36:350–358.

745 White, R. 1991. Mandibulectomy and maxillectomy in the dog: Longterm survival in 100 cases. J Small Anim Pract 32:69–74.

746 White, R., M. Walker, A.M. Legendre, et al. 1990. Development of brachytherapy technique for nasal tumors in dogs. Am J Vet Res 51:1250–1256.

747 Wiley, J.L., K.A. Rook, C.A. Clifford, et al. 2010. Efficacy of doxorubicin‐based chemotherapy for non‐resectable canine subcutaneous haemangiosarcoma. Vet Comp Oncol 8:221–233.

748 Willard, M.D., H. Tvedten, R. Walshaw, et al. 1980. Thymoma in a cat. J Am Vet Med Assoc 176:451–453.

749 Williams, L.E., J.M. Gliatto, R.K. Dodge, et al. 2003. Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985–1995). J Am Vet Med Assoc 223:825–831.

750 Williams, L.E., J.L. Johnson, M.L. Hauck, et al. 2004. Chemotherapy followed by half‐body radiation therapy for canine lymphoma. J Vet Intern Med 18:703–709.

751 Williams, L.E., A.F. Pruitt, and D.E. Thrall. 2010. Chemotherapy followed by abdominal cavity irradiation for feline lymphoblastic lymphoma. Vet Radiol Ultrasound 51:681–687.

752 Wilson, H.M., R. Chun, V.S. Larson, et al. 2007. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990–2004). J Am Vet Med Assoc 231:101–106.

753 Withrow, S.J., E.L. Gillette, P.J. Hoopes, et al. 1989. Intraoperative irradiation of 16 spontaneously occurring canine neoplasms. Vet Surg 18:7–11.

754 Withrow, S.J., J.M. Liptak, R.C. Straw, et al. 2004. Biodegradable cisplatin polymer in limb‐sparing surgery for canine osteosarcoma. Ann Surg Oncol 11:705–713.

755 Withrow, S.J., D.E. Thrall, R.C. Straw, et al. 1993. Intra‐arterial cisplatin with or without radiation in limb‐sparing for canine osteosarcoma. Cancer 71:2484–2490.

756 Wood, C.A., A.S. Moore, J.M. Gliatto, et al. 1998. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991–1993). J Am Anim Hosp Assoc 34:417–421.

757 Worth, A.J., R.M. Zuber, and M. Hocking. 2005. Radioiodide (131I) therapy for the treatment of canine thyroid carcinoma. Aust Vet J 83:208–214.

758 Wouda, R.M., J. Borrego, N.S. Keuler, et al. 2016. Evaluation of adjuvant carboplatin chemotherapy in the management of surgically excised anal sac apocrine gland adenocarcinoma in dogs. Vet Comp Oncol 14:67–80.

759 Wouda, R.M., M.E. Miller, E. Chon, et al. 2015. Clinical effects of vinorelbine administration in the management of various malignant tumor types in dogs: 58 cases (1997–2012). J Am Vet Med Assoc 246:1230–1237.

760 Wycislo, K.L. and T.M. Fan. 2015. The immunotherapy of canine osteosarcoma: A historical and systematic review. J Vet Intern Med 29:759–769.

761 Yamagami, T., T. Kobayashi, K. Takahashi, et al. 1996. Influence of ovariectomy at the time of mastectomy on the prognosis for canine malignant mammary tumours. J Small Anim Pract 37:462–464.

762 Yokoe, I., K. Azuma, K. Hata, et al. 2015. Clinical systemic lupeol administration for canine oral malignant melanoma. Mol Clin Oncol 3:89–92.

763 Yoon, H.Y. and F.A. Mann. 2008. Bilateral pubic and ischial osteotomy for surgical management of caudal colonic and rectal masses in six dogs and a cat. J Am Vet Med Assoc 232:1016–1020.

764 Yu, S., K.J. Wedekind, P.A. Burris, et al. 2011. Controlled level of dietary iodine normalizes serum total thyroxine in cats with naturally occurring hyperthyroidism (abstract). J Vet Intern Med 25:683–684.

765 Zandvliet, M., G.R. Rutteman, and E. Teske. 2013. Prednisolone inclusion in a first‐line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy results. Vet J 197:656–661.

766 Zemann, B.I., A.S. Moore, W.M. Rand, et al. 1998. A combination chemotherapy protocol (Velcap‐L) for dogs with lymphoma. J Vet Intern Med 12:465–470.

767 Zenker, I., K. Meichner, K. Steinle, et al. 2010. Thirteen‐week dose‐intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs. Vet Rec 167:744–748.

768 Zitz, J.C., S.J. Birchard, G.C. Couto, et al. 2008. Results of excision of thymoma in cats and dogs: 20 cases (1984–2005). J Am Vet Med Assoc 232:1186–1192.